IE42601B1 - Sulphamoylbenzoic acid derivatives and processes for preparing them - Google Patents
Sulphamoylbenzoic acid derivatives and processes for preparing themInfo
- Publication number
- IE42601B1 IE42601B1 IE921/75A IE92175A IE42601B1 IE 42601 B1 IE42601 B1 IE 42601B1 IE 921/75 A IE921/75 A IE 921/75A IE 92175 A IE92175 A IE 92175A IE 42601 B1 IE42601 B1 IE 42601B1
- Authority
- IE
- Ireland
- Prior art keywords
- acid
- sulphamoylbenzoic
- compound
- methyl ester
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/402—1-aryl substituted, e.g. piretanide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to a process for the preparation of heterocyclic derivatives of 5-sulfamibenzoic acid of general formula I: (see formula) wherein R1 and R2, the same or different, represent one hydrogen atom or one lower alkyl group, X represents an atom of halogen, hydroxy, alkoxy, phenoxy, optionally substituted with alkyl, halogen, alkoxy and A represents an alkylene group, possibly unsaturated, by oxidation of compounds of general formula II: (see formula) wherein D is a CH 2 OH group, at a temperature between room temperature and 60 degrees C, with an oxidizing agent selected from nickel peroxide, aqueous alkaline permanganate solution or pyridinium hydrochloride solution in chloride medium of methylene, after which the carboxylic acids with bases are converted into their pharmaceutically acceptable salts.
Description
This invention relates to sulphamoylbenzoic acid derivatives and a process for their preparation.
The present invention provides a 5-sulphamoylbenzoic acid derivative of the general formula I in which 2 R and R , which may be identical or different, each represents a hydrogen atom or an alkyl group having from 1 to 4 carbon atoms, and, if R^ represents a hydrogen 2 atom, R may also represent an alkoxymethyl group having from to 4 carbon atoms in the alkoxy radical, a phenoxymethyl . -. group -or a phenyl thiomethyl group, R^ represents a hydrogen atom, a straight or branched chain alkyl group having from 1 to 4 carbon atoms, a cycloalkyl group, having 5. Or 6 ring members, one of which may be replaced by an oxygen or sulphur atom, a phenyl Or benzyl group which may be substituted in the phenyl nucleus by one Or more substituents selected from nitro groups, alkyl groups having from 1 to 3 carbon atoms, alkoxy groups - 2 42601 having from 1 to 5 carbon atoms and halogen atoms, or represents a benzhydryl group or an alkanoyloxymethyl group having 2 to 4 carbon atoms in the alkanoyl part.
X represents a halogen atom, a CF^ or CCl-j group, a straight or branched chain, saturated or unsaturated aliphatic hydrocarbon group having up to 6 carbon atoms, a benzyl group which may be substituted in the phenyl nucleus by one or more substituents selected from halogen atoms, hydroxy and amino groups, and lower alkyl and lower alkoxy groups, A A A A or represents one of the groups -0-R , -S-R , SO-R , SOj-R and NR^rS, in which represents a phenyl group which may be substituted by one or more substituents selected from halogen atoms, OH, CF^ and amino groups, alkyl and alkoxy groups having from 1 to 4 carbon atoms, and SO2NH2 groups, or represents a straight or branched chain alkyl group having from 1 to 4 carbon atoms which may be substituted 5 by a phenyl, pyridyl, furyl or thienyl group, and R represents a hydrogen atom, a straight or branched chain alkyl group having from 1 to 4 carbon atoms, and the group NR R may also represent a saturated, heterocyclic, 5- or 6-membered ring which may be interrupted by an 0-, N- or S-atom, A represents a single bond, or an alkylene chain of 1 to 3 carbon atoms which may be unsaturated, interrupted by 0-, N- or S-atoms or substituted by one or more substituents selected from halogen atoms, alkyl, alkoxy, aralkyl and aryl groups and mono-nuclear hetero-aromatic rings, or A represents an ortho-phenylene radical or the grouping Re, R7 in which Y represents a single bond or an alkylene group 6 7' having from 1 to 4 carbon atoms, and R and R , which may be identical or different, each represents a hydrogen or J 1 halogen atom or an alkyl group having from 1 to 4 carbon atoms.
Preferred compounds of the formula I are those in 12 which the radicals R and R both represent hydrogen atoms, 2 . or R represents a hydrogen atom and R represents a lower alkyl group; R represents a hydrogen atom, a lower alkyl group or a benzyl group which may be substituted as above; 4 4 4 X represents a benzyl, -OR , -SR , or -SO-R , R preferably representing a phenyl radical the phenyl of which may be substituted ih any position and once or several times, by substituents selected from chlorine atoms, OH and CF^ groups, straight or branched chain alkyl groups having from 1 to 3 carbon atoms, alkylamino, dialkyamino or alkoxy of 1 or 2 carbon atoms or NH2; and A represents a single bond or an alkylene chain of 1 or 2 carbon atoms which may be unsaturated and/or substitued once or Several times by substituents selected from halogen atoms, phenyl and aralkyl groups, and lower alkyl and alkoxy groups.
The term lower is used herein to denote groups having up to 4 carbon atoms.
The invention also provides a process for preparing a compound of the general formula I in which the radicals R1 to R3, A and X have the meanings given above, which comprises 42C01 a) reducing the 3-substituted sulphamoylbenzoic acid derivative of the general formula II . 1 3 in which the radicals R to R , A and X have the meanings 5 given above, and in which any hydroxy or amino groups present may be blocked by customary protective groups, and Z represents two hydrogen atoms or one oxygen atom, by means of a boron hydride, for example, in the presence of a F Lewis-acid by a boron hydride or by a complex boron hydride, or‘ b) reacting a 5-halogeno-sulphonylbenzoic acid derivative of the general formula III in which R3, A and X represents a halogen have the meanings given above, and Hal atom, with an amine of the formula HN X*2 1 2 in which R and R have the meanings given above, or c) converting by hydrolysis or by a. mild oxidation reaction a sulphamoyl compound of the general formula IV in which the radicals. R and R , A and X have the meanings given above and D represents a radical which may be . transformed into a carboxylic acid group, into the corresponding 5-sulphamoylbenzoic acid of the formula I (R3~H), or - d) treating a sulphamoylbenzoic acid derivative of the general formula V in which the radicals R1 to R2, A and X have the meanings given above and L represents a leaving group, with an acid or base.in order to eliminate HL, or e) cyclizing a sulphamoyl benzoic acid derivative of the general formula VI (CH ) -HaV j Ζ Π CH~-Hal I 2 above, Hal and Hal , which may be identical or different, each represents a halogen atom, preferably a chlorine or bromine atom, and n represents 0, 1 or 2, by a reaction known per se, for example, by reaction with a metal in accordance with the conditions of the WurtzFittig synthesis or by reaction with a primary amine, NHj or HgS to form a compound of the general formula I, or f) reducing the corresponding 3-N-pyrrolo-compound of the general formula VII (VII) g) hydrolyzing a compound of the general formula VIII (VIII) 2601 in which R , A and X are as defined above, E represents the group It I = C 8~'< R9 ri -Ν' in whichR8, R9 and R^° represent identical or different ’ 8 - --lower alkyl groups and in which ,-R - may also represent a - 8 9 hydrogen atom, and/or two of the substituents R , R and R10 may be linked and, together with the atom(s) to which they are attached fore a ring, and, if desired, in a compound of the formula I obtained according to any one of the methods a) to g), carrying out any one or more of the following reactions h) tp k) ; h) hydrogenating any double bonds present or intro- : ducing double bond(s) by an elimination reaction, i) esterifying a free carboxylic acid of the formula I (R =H) or converting a carboxylic acid ester of the general formula I by hydrolysis or an elimination reaction into the corresponding carboxylic acid (R8=H) and, if desired, . forming a different ester, j) setting free any protected hydroxy or amino groups by separation of the protective group, and k) transforming a carboxylic acid of the formula I (R3=H) by treating with a base or an acid into a salt, especially . a physiologically tolerable salt thereof.
In the case of the process a) according to the invention, it is surprising that it is possible to reduce sulphamoylbenzoic acid derivative of the formula II by means of boron hydride or a complex borohydride in the presence of a Lewis acid without affecting the other groups in the moleculeThe end products are obtained in good yields in this procedure. - 8 30 2601 The sulphamoylbenzolc acid derivatives of the formula II which are used in accordance with the invention may be prepared by various processes. For example, a 3-imido-5-sulphamoylbenzoic acid derivative of the formula XI (Z represents an oxygen atom) is obtained from the corresponding known 3-amino-5-sulphamoyl-benzoic acid derivative 3 of the formula IX in which the radicals R to R and X have the meanings given above, by reacting this amino compound with a dicarboxylic acid derivative of the general formula X which is capable of forming an imide and in which A has the meaning given above, Z represents an oxygen atom and L· denotes .a leaving group, preferably a halogen atom, a trialkylammonium group or the radical OR' of an activated ester. For this acylation reaction, any hydroxyl and/or amino groups in other positions of the molecule should be blocked by means of customary protective groups.
(II) Examples of dicarboxylic acids which can be converted into the corresponding dicarboxylic acid halides are succinic acid, methyl-succinic acid, 2,3-dimethylsuccinic acid, glutaric acid, 2-methylglutaric acid, phthalic acid, cis-cyclopropanedicarboxylic acid, cyclobutane-1,2-cis-dicarboxylic acid, cyclohexane-1,2-cis-dicarboxylic acid, bromosuccinic acid and diglycolic acid. The reaction of such a dicarboxylic acid derivative with an amino compound of the formula IX is generally carried out under the conditions 42G31 . γ . of the known Schotten-Baumann reaction.
- It is also possible to use art anhydride of a dicarboxylic;acid, The carboxylic acid derivative of the formula XI.which is formed initially in many cases, changes into the imido compound. (II) directly, with elimination of water. - ’ / Λ - COOH X (Z=0) (XI) The reaction can be followed easily by thin layer chromatography. Depending on the reaction conditions chosen, particularly if.the reaction mixture is heated to a temperature of from 150 to 25O°C, the cyclised product is obtained in high yields.
An anhydride-is advantageously used in a substantial excess, for example, in a 2- dr 3-fold excess, and the reaction is preferably carried out in the absence of a solvent. It an unsaturated dicarboxylic acid anhydride, for example, maleic anhydride/ is used, a viscous oil is formed on reaction with the amino compound of the formula IX at a temperature from 150 to 200°C, and this oil changes after some time, with elimination of water, into the unsaturated imido compound of the formula XII 42G0 l· 3 6 7 in which the radicals R to R , R , R and X have the meanings given above. The double bond present in this imido compound makes possible a large number of reactions, for example, it can be hydrogenated to give an imido compound of the formula II in which Z represents an oxygen atom and Λ represents an ethylene group.
Compounds of the formula II in which Z represents two hydrogen atoms, may be prepared by various processes. Such a compound is produced, for example, from an amino compound of the formula IX by reaction with an ω-substituted carboxylic acid derivative of the formula X in which Z represents two hydrogen atoms, according to the conditions of the Schotten-Baumann reaction and subsequent cyclisation of tlie resulting amido compound of the formula XIII with elimination of H-L.
The following are example carboxylic acid derivatives of the formula X: ω-chloropropionic acid chloride, ω-chloropropionic acid bromide, ω-chlorobutyric acid 2q chloride, ω-bromobutyric acid chloride, ω-bromobutyric acid phenyl ester and the chloride of trimethylammoniumbutyric acid chloride.
The base used for the elimination of the grouping H-L is preferably a tertiary organic base, for example, pyridine, triethylamine or Ν,Ν-dimethylaniline. The base may be used in a stoichiometric quantity or in a substantial 4 25 31 excess, for example, when it is also used as the Solvent.
An amido or imido derivative of the formula'll may be used in the reduction according to the invention as the free acid or in the form of a salt'which does not interfere with-the reduction, for example, an alkali metal salt or an alkaline earth metal salt.
In order to obtain particularly pure reaction products in high yield, it is advantageous to uSe a 5-sulpha— moylbenzoic acid ester for the reduction. Such an ester can be prepared from the corresponding acid by a known process. Suitable esters are especially alkyl, esters having from 1 to 5 carbon atoms, for example, methyl, ethyl, propyl, butyl and n-pentyl esters, benzyl, £-methoxybenzyl ahd t-butyl esters, benzhydryl esters, and acyloxymethyl esters wherein the acyl radical represents the radical of a lower aliphatic carboxylic acid, for example, an acetyl or tert,-butyryl radical.
Suitable boron hydride reducing agents are complex borohydrides or diborane in the presence of Lewis acids, and diborane alone. In the reduction of a lactam of the formula II (Z= 2 Η), it is possible to use diboranein the presence of a Lewis acid. An imide (Z=0), on the other hand, requires the use of a complex borohydride in the presence of a Lewis acid in order to obtain a good yield.
The reducing agent may be introduced into the reaction mixture while taking suitable protective measures,- for example, the use of nitrogen as an inert gas. When diborane is used, it is simpler to take it up in a solvent and to use the resulting solution for the reduction. Suitable solvents are ethers, for example, tetrahydrofuran or diethylene glycol dimethyl ether.
The complex hydrides of boron used in this method · of reduction are, for example, the alkali metal borohydrides, - 12 42GU1 for example, lithium borohydride, sodium borohydride or potassium borohydride, the alkaline earth metal borohydrides, for example, calcium borohydride, and also zinc borohydride and aluminium borohydride. If a Lewis acid is added, this borohydride reduces the amide or imide groups present in the compound employed of formula II, and it is surprising that the carboxylic acid ester function is not appreciably attacked.
Suitable Lewis-acids within the meaning of the 10 invention are especially aluminium chloride, titanium tetrachloride, tin tetrachloride, cobalt-ΙΙ chloride, iron-ill chloride, mercury-I chloride, zinc chloride, and boron trifluoride and its addition products, for example, boron trifluoride etherate. In this case there is the possibility that diborane may be formed in situ in the reaction of the boron trifluoride etherate, for example With sodium borohydride (c.f. Fieser, Fieser: Reagents for Organic Synthesis, John Wiley and Sons, Inc., New York, Vol.l, page 199). 2o In order to obtain a particularly high yield and particular pure end products, it is advantageous first to . introduce the Lewis acid together with the compound of the formula II and then to add the complex borohydride.
It is particularly advantageous to use the Lewis acid in excess and the complex borohydride in an at least stoichiometric quantity, relative to the amide group to be reduced. Thus, advantageous results are obtained by adding, for example in the case of titanium tetrachloride, t three times the stoichiometric quantity of NaBH^, and when using boron trifluoride etherate, by using the complex borohydride in the stoichiometric quantity, relative to the particular number of amide groups to be reduced. a 2G Ji In carrying out the reduction it is unimportant whether the substances to be reduced are introduced as imido compounds Of the formula II i.e. Z represents an oxygen atom or as amido compounds i.e. Z represents two hydrogen atoms. Surprisingly, in.a one-vessel reaction, an imido compound changes directly into the sulphamoylbenzoic acid derivative of the formula I. The reduction is carried out in a solvent. Examples of suitable solvents are ethers, for example, tetrahydrofuran and diethylene glycol dimethyl ether (diglym). The solvent in which the reduction is carried out may be the same as that in which the boron hydride is dissolved, but can also be different therefrom.
The reduction may be carried out within a wide range of temperatures, for example, at room temperature or at a slightly elevated temperature. While a secondary amine reacts with diborane and a lactam with diborane and a Lewis acid preferably at a slightly elevated temperature (40° to 60°C), the reduction with a complex borohydride and a Lewis acid, in particular with an imide , often proceeds favourably in the temperature range of from 0° to 20°C. If somewhat longer reaction times are acceptable, it is also possible to carry out the reduction in the cold. Theduration of the reduction depends on the reaction components used and on the temperature selected.
In a preferred method of the process of the invention, the 5-Sulphamoylbenzoic acid derivative of the formula II is first introduced together with the Lewis acid, in an inert solvent and then a solution of the complex borohydride or, if appropriate, a suspension of the complex borohydride in the same or different solvent is added at room temperature and the mixture is stirred for a short time. The complex borohydride can also be added directly in solid form. In order to accelerate the reaction, it may also be carried out at - 14 42G01 elevated temperature or the mixture may be heated to 50° to 80°C for about 1 hour after completing the addition of the reducing agent.
Another method comprises first introducing the substance to be reduced together with the complex borohydride and then adding the Lewis acid at room temperature. Sodium borohydride is particularly suitable as the complex borohydride. Here too, it may be advantageous, to achieve a faster conversion, to heat the mixture to 4O°-7O°C for about 1 hour after the end of the addition of the Lewis acid. With the aid of thin layer chromatography it is possible to follow the progress of the reaction by the appearance of the intensive light-blue fluorescence (in the region of 366 nm) of the resulting compound of the formula 1. Xn the reduction according to the invention it Is possible that any double bonds which may be present in tlie group A may be reduced simultaneously.
The resulting compound of formula 1 can be isolated in several ways. A preferred method of working up comprises adding waterand small quantities of an acid in order to free the solution of the reaction product from any reducing agent which may still be present and then precipitating the resulting 5-sulphamoylbenzoic acid ester by adding a nonsolvent. When diethylene glycol dimethyl ether is used, a particularly suitable non-solvent is water. The resulting 5-sulphamoylbenzoic acid ester of the formula I generally crystallizes almost quantitatively with high purity. Subsequently, any substituents which are present in the radical X of the sulphamoylbenzoic acid derivatives of the general formula I and which are protected by protective groups may be liberated, for example, the £-hydroxyl group may be obtained in free form by saponifying the corresponding acetate. 426 31 It is also possible to obtain a 5-sulphamoylbenzoic acid of the formula I directly by partially concentrating the reaction mixture after decomposition of the excess of reducing agent, adding a dilute base and, if appropriate, heating for a short time. Sodium hydroxide solution, for example, may be used as the base. In this case, the 5-sulphamoylbenzoic acid of the formula I can be isolated directly in the form of a salt. The free acid may be obtained by acidification. Owing to the smooth course of the formation of the 3-imido- or 3-amido-5-sulphamoylbenzoic acid derivative of the formula II, the 5-sulphamoylbenzoic acid derivative of the formula I may be obtained according to method a) with high purity and with a high space-time yield.
The reduction can be carried equally successfully With an imide or amide if the C-C chain contains substituents which are split off easily with formation of a carboncarbon double bond. Thus, for example, a 3-pyrroline derivative of the formula I in which A represents a II H ' I I . c — ·· - C — . group, is obtained when 2-bromosuccinic acid is used as the starting material for the reactant of the formula VIII.
A Δ-3-pyrrolihe derivative can be modified chemically in known manner, for example, it may be hydrogenated cataly25 tically to give a sulphamoylbenzoic acid derivative of the formula I in which A represents an ethylene group and Witha heterocyclic substituent in the 3-position, or it may be subjected to the usual addition reactions.
A 5-halogenosulphonylbenzoic acid derivative of the formula III required for method b) may be obtained in various ways, for example, from an aminobenzoic acid derivative of the formula XIV 42C01 according to the reaction sequence described by Meerwein in J. pr. (2) 152, 251 (1939) or DBP 859,461.
The halogenosulphonylbenzoic acid deriva_ive of formula III is reacted in known manner with an amine of the formula R1 ' / HN to give a compound of the formula I. An aminobenzoic acid derivative of the formula XIV may be obtained in various ways, for example, from a known amino-nitrobenzoic acid derivative of the formula XV according to the reaction scheme (XVI) by reacting the compound of formula XV with a carboxylic acid derivative of the formula X as described above and subsequently reducing the resulting compound of the formula XVI by means of a boron hydride e.g. diborane or a complex borohydride in the presence of a Lewis acid, to give a nitrobenzoic acid ester XVII. The nitro group of this compound is then reduced, advantageously by catalytic hydrogenation : 4260 1 in the presence of Raney nickel or by another conventional reduction! method.
The compound XIV can be prepared ip a particularly advantageous manner as follows: In the reduction of a 3-amido- or 3-imido-coflipound of the formula XVI or XVIII respectively, the same conditions can be used as those described under method a). In this respect it is surprising that the reduction proceeds specifically in the presence of a nitro group.
The compounds of the general formula IV used in method c) are accessible in various ways. For example, a compound in which D in formula IV represents a CI^OHgroup may be obtained from a carboxylic acid derivative of the formula I by means Of an excess of reducing agent. This reaction can be observed as a side-reaction When treating an imido- or amido-derivative of the formula II according to method a) at toohigh a temperature for a prolonged period of time with an excess of reducing agent. Thus, according to method c), it is possible to reconvert a compound of the formula IV i.e. a compound of formula I which has been reduced too far into the desired compound of the formula I by treatment with an oxidizing agent.
The method of conversion of a compound of the formula IV into a compound of the formula I depends on the nature of the substituent D, If D represents a CH2~ halogeno group, a CE^OCOCH^ group or a CH=O group, the - 18 42601 desired products may be obtained by oxidation, as already described. If D represents a nitrile group, an amide is formed on alkaline hydrolysis and may subsequently be converted into the free carboxylic acid, for example, by further hydrolysis. Alternatively, reaction of a nitrile with alcoholic hydrochloric acid gives the imino-ester which can be converted by hydrolysis into the ester compound, and, if desired, into the corresponding carboxylic acid.
A sulphamoylbenzoic acid derivative of the formula V, used in method d), may be produced in various ways, for example, from a sulphamoylbenzoic acid derivative of the formula XIII by reducing the amide group with a boron hydride alone or a complex borohydride in the presence of a Lewis acid in the manner already described. It is surprising in this reduction that the amide group is reduced without the leaving group L being affected. As the leaving group L, there is preferably used a halogen atom, an OH group, an active ester group, for example, a o-tosyl group, a trialkylammonium or pyridinium group.
The cyclization of a compound of the formula V with the elimination of HL, may be carried out under basic or acidic conditions. If, for example, L represents a halogen atom, preferably a chlorine or bromine atom, cyclization is effected by treatment with an alkali. In an acid medium, the cyclization is carried out according to the method described in Ber.dtsch. 2G 31 chem.Ges.42, 3427 (1909) (Summary in Chem.Rev.63, 55 (1963)), whereby a salt of a carboxylic acid of the formula I (R3 represents a hydrogen atom), is formed. As the base which may be used in the separation reaction, there may be mentioned '5 triethylamine, an alkali metal hydroxide, N,N-dimethylaniline or an alkali metal acetate.
A compound of the formula I may also be prepared f ran a 3-amino-compound of the formula IX by reaction with a compound of the formula io l-ch2-a-ch2-l, whereby the -CH2-A-CH2-part of the molecule is cyclised with the 3-amino group of IX with separation of 2 moles of v IIL to give a compound of the formula I.
For this purpose, the compound IX Is reacted in an j5 organic solvent, for example, acetone, dimethylformamide, ethanol, or a mixture of such solvents, with an excess of the compound of the formula L-CH2-A-CH2-L, suitably by heating for several hours to days under reflux. It is. advantageous, if L represents a bromine or chlorine atom, to add 20 an excess of an alkali metal iodide to the reaction mixture.
In some cases, an auxiliary base,.for example, pyridine, triethylamine, NaHCOj or Na-acetate, accelerates the reaction, .A sulphamoylbenzoic acid derivative of the formulaVI used in method e) may be prepared by various processes, for 25 example, from a compound of the formula V in which A represents -.= a single bond or an unsubstituted or substituted methylene or . - ethylene group, and L represents a halogen atom, preferably a chlorine or bromine atom, by reaction with formaldehyde . and a hydrohalic acid or by a further reaction with ah w-haloj0 genooarboxylic acid with formation of an amido compound of the formula XIX which is reduced in the manner already described (cf. the following reaction scheme). - 20 42GG1 H2C CH2L „2 (V) l\ .ζΛ\ HCHO/H/Hal CH2 CI12-1' The subsequent cyclization is effected in a known manner for example, according to the method described by Wurtz, by the reaction of a compound of the formula VI with metallic , sodium or by the action of Zn on a boiling alcoholic solution of a compound of formula VI, as described in J. prakt. chem./2/36, 300 (1887). This method is particularly suitable for the preparation of a compound of formula I having a 4-membered or 5-membered ring in the 3-position.
It is also possible to react a compound of the formula VI with a nucleophilic compound, for example, a primary amine, NH^ or HjS, whereby the ring in the 3-position is closed with incorporation of the heteroatom of the nucleophilic reagent.
A compound of the formula VII used in method f) may be obtained from a 3-amino-5-sulphamoylbenzoic acid derivative of the formula IX by reaction in the usual manner with a 2,5dimethoxytetrahydrofuran of the formula '42601 7 in which R and R have the meanings given above. Reduction of the resulting pyrrolo-compound VII is effected preferably by catalytic hydrogenation with a catalyst usually employed for such a purpose. The benzoic acid derivatives of the formula VIII used in method g) and a process for preparing them are described in British Patent Specification · No. 1,505,636.
The process for preparing the compound of formula VIII comprises (a) (i) reacting a compound of formula XX (XX) in -which Ε , X and R - have the meanings given above, with a compound of the formula XXI A — C \ L (XXI) in which A and have the meanings given above and L represents a leaving group or both symbols L together represent an oxygen atom, to give a compound of formula XXII - 22 4 2 6 0 1 /A\ Λ-c \ / c=z (XXII) in which Z1 represents an oxygen atom or two hydrogen 2 atoms and Z represents an oxygen atom, or (a)(ii) reacting a compound of formula XXa (XXa) in which compound X and R have the meanings given above, with a of formula XXI A- (XXI) in which A, Z3 and L have the meanings given above and introducing the group E,which has the meaning given above, into the resulting compound to give a compound of formula XXII in which Z1 represents an oxygen atom or two hydrogen atoms and Z represents an oxygen atom, and (bj reducing the compound of formula XXII resulting from (a)(i) or (a) (ii) by means of a boron hydride to give the corresponding compound of formula VIII.
The compound of formula XX may be prepared by a process which comprises (x) nitrating a sulphamoylbenzoic acid derivative of formula XXIII 2 601 in which Y represents a halogen atom and E and R are as defined above, . (y) reacting the resulting compound of formula XXIV (XXIV) ' in which R ,Y and E are as defined above, with a compound of formula XH in which X is as defined above. ; (z) reducing the resulting compound of formula XXV in which Ε, X and R have the meanings given above.
A compound of formula XXa may be prepared by carrying out the reactions (χ), (y) and (z) described above using the corresponding, unprotected compound of formula XXIIIa Y'^-xv (XXIIIa) h2no2s-/J^>/>coor3 as starting material. This process may be modified to produce a compound of formula XX by introducing the group E into any of the intermediates i.e. into the unprotected compounds corresponding to compounds XXIV, XV and XX.
The compound of formula XXIIIa is known, and the group E may be introduced into it or any other appropriate compound by any of the various known condensation methods.
The following literature is cited by way of example of documents disclosing such methods: J.Org.Chem.25 (1960), 352-356; Zh.Org.Khim.8 (1972), 286-291; Liebigs Ann.Chem.750 (1971), 42; Zh.Org.Khim.6 (1970), 9,1855; 10 B.94 (1961), 2731-2737; Ang.Ch.78 (1966), 147-148; Ang.Ch.8O (1968), 281-282; B.9J7 (1964),483-489; B.96 (1963), 802-812; J.Org.Chem.27 (1962), 4566-4570; Ahg.Ch.74 (1962), 781-782, and Doklady Akad.SSSR 145 (1962), 584.
As the compound of the general formula XXIII, there 15 may be used for example, any of the following derivatives: Compound No. R8 R9 R10 Y 1 H ch3 ch3 Cl 2 ch3 ch3 Ctl3 Cl 3 IIC2H5C2H5 Cl 4C4H9 ch3 ch3 Cl 5 H ch3 ch3 F 6 H ch3 1 ch3 Br 7CH3 1 -CH2-CH2-( :h2-ch2-ch2- Cl 8 -ch2-ch2 -ch2- ch3 Cl A compound of the formula XXIII may be prepared according to any of the above methods described in the literature or by an analogous method. Instead of the acids listed above as compounds 1 to 7, there may be used, for example,.the corresponding methyl or ethyl ester.
Nitration of the benzoic acid derivative of the formula XXIII .can be effected in various ways. For example, the benzoic acid derivative may be introduced into one of the nitrating mixtures conventionally used for the IQ . nitration of inert aromatic substances (cf. manual Organicum, page 288, .Edition 1967). The process may also be carried out by dissolving the benzoic acid derivative of the formula XXIII in oleum and controlling the nitration by dropwise addition of nitric acid. £5 It is surprising that it is possible to nitrate a ben- , zoic acid derivative of the general formula XXIII without modification of other groups in the molecule merely by the introduction of the protective group E into the sulphonamide radical. , The reaction temperature is relatively low; preferably , temperatures in the range of from 55° to 70°C are maintained.
It is advantageous first to introduce into a suitable vessel a nitrating acid. of oleum and fuming nitric acid, then to add the compound of formula XXIII and to heat the -O reaction mixture to 55° to 60°C.
The course of the nitration can be followed by thinlayer chromatography, isolation of the final product is carried out in the usual manner, for example by pouring the reaction mixture onto ice and separating by filtration the crystals that have precipitated. - 26 42601 As mentioned above, an acid or ester of the general formula XXIII may be used. When an ester is used small amounts of the· acid of the formula XXIV (with R3-II) are obtained in addition to the ester. Such a resulting mixture can be separated in the usual manner, for example, by treatment with aqueous sodium carbonate. A resulting acid of the 3 formula XXIV (in which R is hydrogen) is then esterified in the usual manner, for example, it is converted into its acid chloride which, upon addition of an alcohol, yields the corresponding ester of the formula XXIV.
Suitable alcohols for the esterification are, in particular, alkyl alcohols having from 1 to 4 carbon atoms, for example, methanol, ethanol, propanol, butanol, isopropanol or isobutanol, and aralkylalcohols, for example, benzylalcohols or benzhydrol. It is advantageous to use the alcohol in a 5- to 20-fold molar excess or to use it simultaneously as solvent. A tert.butyl ester or benzhydryl esters can be prepared according to other known methods.
In .the next step, the ester of the formula XXIV is converted fay reaction with a compound of the formula XI) into a compound of the formula XXV. It is surprising that a 3 compound of the general formula XXIV in which R represents an alkyl group can be reacted under anhydrous conditions with good yields with compounds of the general formula XH.
As the compound of the formula XH, there may be used, for example, phenol, 4-methylphenol, 3-methylphenol, 2-methylphenol, 4-chlorophenol, 3-trifluoromethylphenol, 3,5-dimethylphenol, 2,4-dimethylphenol, 4-methoxyphenol, 3-methoxyphenol, 4- propylphenol; thiophenol or a thiophenol substituted in the same manner as the phenols listed above; N-moLhylaniline, benzenesulphinic acid, pyrrolidine, N-methylpiperazine, - methyl-2-mercapto-l,3,4-thiadiazole,or 1-methyl-5-mercapto1,2,3,4-tetrazole. Any additionally present functional groups in XH as well as other OH-groups, NH0- or mercapto groups are 2 601 blocked,by the usual protective groups, for· example, by acylation. 4 Compounds of the general formula HOR and HSR , in 4 which the radical R has the meanings given above, are of 5 great importance. Among them, the thiophenol and phenol derivatives, which may be substituted as already indicated, are of particular importance.
The reaction may be carried out without solvent, but it is advantageous to use a solvent. Particularly suitable solvents are organic solvents, for example, ether and tert, carboxamide, in particular diglyme, dimethylformamide or hexamethylphosphoric aeid-tris-amide (HMPT).
The compound X-H may be used as such in the presence of a base or may be used in the form of an alkali metal salt or alkaline earth metal salt thereof. As the base, an alcoholate or an alkali metal amide may be used.
The thiophenol, or phenol derivative is reacted in the form of the anions thereof, among these, the alkali metal salts, especially the sodium and potassium salts, have proved particularly useful, . The reaction may be carried out in the presence or in the absence of a solvent. Without a solvent, the components are heated, for example, to a temperature within the range of from 100° to 200°C, preferably from 140° to 180°C. The resulting product, cab be isolated in the usual manner, for example, by dissolving the, molten products in a solvent and subsequently precipitating them, by the addition of water or of an organic non-solvent.
The reaction with a phenolate or thiophenolate in a solvent at a temperature within the range of from 100° to 200°C, preferably from 120° to 160°C, however, is particularly advan- tageous. - 28 42601 As the solvent, there may be used an organic solvent, in particular a tertiary carboxamide, polyester or highboiling point solvent, for example, HMPT or tetramethylenesulphone. Particularly advantageous is the reaction of an ester of the formula XX in a tertiary carboxamide, for example, dimethylformamide or dimethylacetamide. Depending on the reaction temperature selected, the reaction is generally completed after 1 to 6 hours.
The isolation of the final product of the formula X is effected in the usual manner, for example, the inorganic salts are first filtered off and the reaction product is then precipitated by the addition of a non-solvent or the reaction mixture is poured into water or onto ice and the reaction product that has precipitated is isolated.
A compound of the formula XXV in which X represents a SOR^ or SC^R^ group in the 4-position, may he obtained from the corresponding compound in which X represents SR by oxidation according to a known method, for example, an S-oxide is obtained by oxidation with per-acetic acid in dimethylformamide at a low temperature, while an S-dioxide is formed upon addition of an excess of an oxidizing agent at a more elevated temperature.
The reduction of the nitro group in a benzoic acid derivative of the formula XXV may be effected in the usual manner, for example, by catalytic hydrogenation . As the catalyst, Raney nickel or a noble metal catalyst,for example, palladium on charcoal or platinum oxide, is preferably used (cf. for example Organokum, pages 271-277 - pages 507-510).
As the solvent for the reduction, an organic solvent, for example, methanol or ethanol, ethyl acetate, dioxane or another polar solvent, in particular an amide, for example, dimethylformamide, dimethylacetamide or HMPT, is preferably used. ,42601 . Hydrogenation may be effected at room1 temperature ' and under normal pressure or at an elevated temperature and increased pressure, for example, at 5O°C and 100 atmospheres gauge in an autoclave.
A3-imidobenzoic acid derivative of the general formula XXII may be prepared in various ways. For example, it may be obtained by reacting the amino compound XX with a dicarboxylic acid derivative of the general formula XXI which is capable Of forming an imide. The reaction is' · carried out in a manner analogous to the reaction described under method a) of the compounds IX and X to a compound of the formula II, The reaction can be easily followed by thin-layer chromatography, since the amino compounds XX fluoresce at 366 ηίμ, while the compounds of formula XXII show no fluorescence.
An amido-compound of the formula XXII in which Z represents 2 hydrogen atoms, may be prepared in a manner analogous to that described under method a) for the compounds II, in -which Z stands for 2 H-atoms. 2q The carboxylic acid derivatives of the formula XXI correspond to the above-described compounds of the formula X.
In the reduction of a compound of the formula XXII, a benzoic acid derivative of the general formula VIII which 25 is substituted heterocyclically in the 3-position, is obtained. In order to obtain a particularly pure product with high yield, it is advantageous to use a benzoic acid ester of the formula XXII. The reduction is effected as described under method a), A 5-sulphamoyl-benzoic acid of the formula I (i.e.
R represents a hydrogen atom), may be obtained by alkaline hydrolysis of a compound of the general formula VIII by heating for several hours in a sodium or potassium hydroxide solution on a steam bath. Thereby, the ester is saponified - 30 426 01 and the protective group E as well as any other protective groups present are split off.
A 5-sulphamoylbenzoic acid of the formula I may I also be obtained directly by partially concentrating the ,. reaction mixture after destruction of the excess of reduc5 ing agent, adding a base and heating for a prolonged period of time. As the base, sodium hydroxide solution may be used. The 5-sulphamoylbenzoic acid of the formula I can therefore be isolated directly in the form of 10 a salt and the free acid obtained by acidification.
Subsequent to the methods listed under a) to g), any double bonds which may be present in the compounds of the formula I of the invention may be hydrogenated in the customary manner, for example, by catalytic hydrogenation. jj. Conversely, it is also possible subsequently to introduce double bond(s) by an elimination reaction, for example, by separating hydrogen halide from a halogenated compound, by separating water from a hydroxy compound or by any other conventional splitting reaction. 2θ If a free carboxylic acid of the formula I is first obtained, this may be converted in a usual manner into esters. For this purpose, an alcohol of the formula R3OH or a functional derivative thereof is used or esterification is carried out in another known manner. Conversely, if a carboxylic acid ester of the general formula I is first obtained, it may be converted into the corresponding free carboxylic acid. Hydrolysis is generally used for this purpose but, in suitable cases, hydrogenolysis or other elimination reactions may be used, it is therefore possible, for example, to split an alkyl ester by alkaline hydrolysis; an aralkyl ester, in particular a £-nitrobenzyl ester, by hydrogenolysis; and a tert.-butyl ester by elimination of isobutylene upon treatment with trifluoroacetic acid. 43601 /. - -.. L · .
A free carboxylic acid may be converted into a salt, especially a physiologically tolerable salt, by reaction with an appropriate base, for example,an alkali metal, alkaline earth metal or ammonium hydroxide or carbonate. Finally, it S’ is possible to obtain a compound of the formula I by separating, ih the' last reaction stage, one of the customary protective groups used for protecting the hydroxyl and, amino groups,, whereby, for example acylated hydroxyl groups are hydrolyzed in the customary manner. The protective groups of hydroxyl and, amino groups are required especially in the preparation of the starting materials of the formula II,. in order to prevent aclyation With the carboxylic acid derivative of the. formula X at undesired positions. In this case, the reduction according to the invention by method a) is often carried out with the protected hydroxy and amino compounds and the separation of the protective group is only . carried out, as described above, after the.reduction. However, even in the other methods it may be suitable to block reactive substituents which are split off in the last ..reaction stage:.
A large number of pharmacologically active agents can be prepared by the process of the invention, especially diuretics and saluretics, some of which are specified in the Table hereinafter: ; 3-N-azetidino-4‘-phenoxy-5-sulphamoylbenzoic acid 3-N-aziridino-4-phenoxy-5-sulphamoylbenzoic acid 3-N-pyrrolidino-4-chloro-5-sulphamoylbenzoic acid ------ 3-N-pyrrolidino-4-chlorophenoxy-5-sulphamoylbenzoic ' / aoid 3-N-pyrrolidino-4-(4'-methylphenoxy)-5-sulphamoylbenzoic acid 3-N-pyrrolidino-4-(3*-methylphenoxy)-5-SUlphamoylbenzoic acid - 32 4 2 6 01 3-N-pyrrolidino-4-(2'-methyIphenoxy)-5-sulphamoylbenzoic acid 3-N-pyrrolidino-4-(2', 4'-dimethyIphenoxy)-5-sulphamoylbenzoic acid 3-N-pyrrolidino-4-(3',5'-dimethyIphenoxy)-5-sulphamoylbenzoic acid 3-N-pyrrolidino-4-(4'-hydroxyphenoxy)-5-Sulphamoylbenzoic acid 3-N-pyrrolidino-4-(4'-methoxyphenoxy)-5-sulphamoylbenzoic acid 3-N-pyrrolidino-4-(4'-trifluoromethy1-phenoxy)-5sulphamoylbenzoic acid 3-N-pyrrolidino-4-(3'-trifluoromethy1-phenoxy)-5sulphamoylbenzoic acid 3-N-pyrrolidino-4-(4'-propyIphenoxy)-5-sulphamoylbenzoic acid 3-N-pyrrolidino-4-n-butoxy-5-sulphamoylbenzoic acid 3-N-pyrrolidino-4-n-pentoxy-5-sulphamoylbenzoic acid 3-N-pyrrolidino-4-phenylthio-5-sulphamoylbenzoic acid 3-N-pyrrolidino-4-(4’-dimethylaminophenoxy)-5-sulphamoylbenzoic acid 3-N-pyrrolidino-4-(4'-aminophenoxy)-5-sulphamoylbenzoic acid 3-N-pyrrolidino-4-phenylsulphoxy-5-sulphamoylbenzoic acid 3-N-pyrrolidino-4-phenylsulphonyl-5-sulphamoylbenzoic acid 3-N-pyrrolidino-4-trichloromethyl-5-sulphamoylbenzoic acid 3-N-pyrrolidino-4-trifluoromethyl-5-sulphamoylbenzoic acid .- 42601 3-N-pyrrolidino-4-(N-methyl-N-pheriyl)-amino-5sulphamoylbenzoic acid 3-N-pyrrolidino-4-benzyI-5-sulphamoylbenzqic acid 3-N-pyrrOlidino-4-(4'-methyIbenzyl)-5-sulphamoylbenzoic acid 3-N-pyrrolidino-4-(4'-methoxybenzyl)-5-sulphamoylbenzoic acid 3-N-pyrrolidino-4-(4'-chlorobenzyl)-5-sulphamoyl10 benzoic acid 3-N-pyrrolidino-4-methyl-5-sulphamoylbenzbic acid 3-N-pyrrolidino-4-n-butyl-5-sulphamoylbenzoic acid 3-N-(3-methylpyrrolidino)-4-chloro-5-sulphamoyl15 benzoic acid .3-N-(3-methylpyrrolidino)-4-£-chIorophenoxy-5-sulphamoylbenzoic acid 3-N-(3-methylpyrrolidino)-4-(41-methylphenoxy)-5-sulphamoylbenzoic acid 3-N- (3-methylpyrrolidino)-4-(3‘-methylphenoxy)-5sulphamoylbenzoic acid 3-N-(3-methylpyrrolidino)-4-(21-methylphenoxy)-5sulphamoylbenzoic acid 3-N-(3-methylpyrrolidino)-4-(2), 4'-dimethylphenoxy)25 5-sulphamoylbenzoic acid 3-N-(3-methylpyrrolidino)-4-(3',5'-dimethylphenoxy)5-sulphamoylbenzoic acid 3-N-(3-methylpyrrolidino)-4-(4'-hydroxyphenoxy)-5-sulphamoylbenzoic acid 3-N-(3-methylpyrrolidino)-4-(4'-methoxyphenoxy)-5sulphamoylbenzoic acid 3-N-(3-methylpyrrolidino)-4-(4'-trifluoromethyi-- · I ... phenoxy)-5-sulphamoylbenzoic acid - 34 42601 3-N-(3-methylpyrrolidino)-4-(3'-trifluoromethy1phenoxy)-5-sulphamoylbenzoic acid 3-N-(3-methylpyrrolidino)-4-(4'-propylphenoxy)-5sulphamoylbenzoic acid 3-N-(3-methylpyrrolidino)-4-n-butoxy-5-sulphamoylbenzoic acid 3-N-(3-methylpyrrolidino)-4-n-pentoxy-5-sulphamoyl‘ benzoic acid 3-N-(3-methylpyrrolidino)-4-phenylthio-5-sulphamoylbenzoic acid 3-N- (3-methylpyrrolidino)-4-(4'-dimethylaminophenoxy)5-sulphamoylbenzoic acid 3-N-(3-methylpyrrolidinoj-4-(4’-aminophenoxy)-5sulphamoylbenzoic acid 3-N-(3-methylpyrrolidino)-4-phenylsulphoxy-5-sulphamoylhenzoic acid 3-N-(3-methylpyrrolidino)-4-phenylsulphonyl-5-sulphamoylbenzoic acid 3-N-(3-methylpyrrolidino)-4-trichloromethyl-5-sulphamoylbenzoic acid 3-N-(3-methylpyrrolidino)-4-trifluoromethyl-5-sulphamoylbenzoic acid 3-N-(3-methylpyrrolidino)-4-(N-methyl-N-phenyl)-amino5-sulphamoylbenzoic acid 3-N-(3-methylpyrrolidino)-4-benzyl-5-sulphamoylbenzoic acid 3-N-(3-methylpyrrolidino)-4-(4'-methylbenzyl)-5sulphamoylbenzoic acid 3-N-(3-methylpyrrolidino)-4-(4'-methoxybenzyl)-5sulphamoylbenzoic acid 3-N- (3-methylpyrrolidino)-4-(4’-ehlorobenzyl)-5sulphamoylbenzoic acid 3-N-(3-methylpyrrolidino)-4-methyl-5-sulphamoylbenzoic acid 4 2601 3-N-(3-methylpyrrolidino)-4-n-butyl-5-sulphamoyl't benzoic acid 3-Nr (3,3-dimethylpyrrolidino)-4-phenoxy-5-sulphamoylbenzoic acid 3-N~(3,3-dimethylpyrrolidino)-4-(4'-methylphenoxy)-5sulphamoylbenzoic acid 3-N-(3,3-dimethylpyrrolidino)-4-benzyl-5-sulphamoylbenzoic acid 3-N-(3,4-dimethylpyrrolidino)-4-phenoxy-5-sulphamoyl~ benzoic acid 3-N-(3,4-dimethylpyrrolidiho)-4-(4’-methylphenoxy)• 5-sulphamoylbenzoic acid 3-N-(3,4-dimethy lpyrrolidino)-4-benzyl-5-sulphaitioylbenzoic acid 3-N-A3-pyrrolih0-4-phenoxy-5-sulphamoyibenzoic acid 3-N-A3-pyrrolino-4-(4’-methylphenoxy)-5-sulphamoylbenzoic acid 3-N-A3-pyrrolino-4-(4’-ohlorophenoxy)-5-sulphamoyl2o benzoic acid 3-N-A3-pyrrolino-4-benzyl-5-sulphamoylbenzoic acid 3-fl-(3-phenylpyrrolidinyl)}-4-phenoxy-5-sulphamoylbenzolc acid 3- {1-(3-phenylpyrrolidinyl))-4-(4'-methylphenoxy)25 sulphamoylbenzoic acid 3-N-(3-ohloropyrrolidino)-4-phenoxy-5-sulphamoylbenzoic acid 3-N-(3-brom0pyrrolidino)-4-phenoXy-5-sulphamoylbenzoic . acid 3q 3-N-piperidino-4-chloro-5-sulphamoylbenZoic acid 3-N-piperidino-4-p-chlorophenoxy-5-sulphamoylbenzoic acid 3-N-piperidino-4-(4’-methylphenoxy)-5-SulphamOylbenzoic acid' . ' - 36 4 2601 3-N-piperidino-4-(3'-methylphenoxy)-5-sulphamoylbenzoic acid 3-N-piperidino-4-(2'-methylphenoxy)-5-sulphamoylbenzoic acid 3-N-piperidino-4-(2',4'-dimethylphenoxy)-5-sulphamoylbenzoic gcid 3-N-piperidino-4-(3',5'-dimethylphenoxy)-5-sulphamoylbenzoic acid 3-N-piperidino-4- (4'-hydroxyphenoxy)-5-sulphamoylbenzoic acid 3-N-piperidino~4-(4’-trifluoromethyl-phenOxy)-5-sulphamoylbenzoic acid 3-N-piperidino-4-(4'-propylphenoxy)-5-sulphamoylbenzoic acid 3-N-piperidino-4-n-butoxy~5-sulphamoylbenzoic acid 3-N-piperidino~4-n-pentoxy-5-sulphamoylbenzoic acid 3-N-piperidino-4-phenylthio-5-sulphamoylbenzoic acid 3-N-piperidino-4-(4'-dimethylaminophenoxy)-5-sulphamoylbenzoic acid 3-N-piperidino-4-(4'-aminophenoxy)-5-sulphamoylbenzoic acid 3-N-piperidino-4-phenylsulphoxy-5-sulphamoylbenzoic acid 3-N-piperidino-4-phenylsulphonyl-5-sulphamoylbenzolc acid 3-N-piperidino-4-trifluoromethyl-5-sulphamoylbenzoic acid 3-N-piperidino-4-(N-methyl-N-phenyl)-amino~5-sulphamoylbenzoic acid 3-N-piperidino-4-(4'-methoxyphenoxy)-5-sulphamoylbenzoic acid 3-N-piperidino-4-(4'-methoxyphenoxy)-5-sulphamoylbenzoic acid 426 01 the corresponding -N-methylsulphamoyl 5-N-ethylsulphamoyl 5-N-methoxymethylsulphamoyl, and —N-butoxymethylsulphamoyl, compounds; benzoic acid methyl esters, benzoic acid ethyl esters, benzoic acid benzyl esters, and - benzoic acid tert.-butyl esters.
The sulphamoylbenzoic acid derivatives of the formula I and theit physiologically tolerable salts are diuretics and Saluretics which can be used as pharmaceutical agents in human and veterinary medicine.
The invention therefore provides a pharmaceutical preparation Which comprises a compound of the general formula I or a physiologically tolerable salt thereof in admixture or conjunction with a pharmaceutically suitable carrier. The preparation may be in a form suitable for administration enterally, for example perorally by means of a sound, or parenterally, for example, by intravenous injection, intramuscular injection, or subcutaneous injection.
The preparations are preferably in unit dosage form, for example, as capsules, dragees, tablets or ampoules containing a solution of the active substance With various additives.
There is advantageously from 0.5 to 100 mg of the active substance per unit dose.
The preparations, particularly for human beings, may comprise the active substance alone or in combination with another salidiuretic substance having a different mode of action. A j_ compound of the invention may be administered, with various other medicaments, separately from them, alternatively with them or in combination with them. In this respect, there may be mentioned SPIRONOLACTON, TRIAMTEREN, AMILORID and other + K -retaining compounds, alternating with long-acting sali3 diuretics of the type of CHLORTHALIDON or others, together with, or separately from, the potassium-containing compounds (salts or the like) which replace the loss of K+ which is observed in salidiuresis.
The preparations of the invention arc suitable for the lo treatment of oedematous diseases, for example, oedemas caused by various cardiac, renal and hepatic conditions and other similar disorders of the water balance and electrolyte metabolism.
The following Examples illustrate the invention. If not stated otherwise, temperatures are given in degrees celcius.
EXAMPLE 1 3-N-Pyrrolidino-4-phenoxy-5-sulphamoylbenzoic acid methyl ester (a) 3-Nitro-4-phenoxy-5-sulphamoylbenzoic acid methyl ester 2Q 34 g ('-''O.l mol) of 3-nitro-4-phenoxy-5-sulphamoylbenzoic acid are dissolved in 150 ml of methanol and are heated to the boil. 5.4 ml of concentrated Η,,δΟ^ are then added slowly dropwise and the mixture is heated at reflux temperature for 10 hours. On cooling, 3-nitro-4-phenoxy-5-sulphamoylbenzoic acid methyl ester crystallises.
It can be reerystallised from methanol/acetone.
Molting point: 181-182°C. (b) 3-Amino-4-phenoxy-5-sulphamoylbenzoic acid methyl ester g (—0.1 mol) of 3-nitro-4-phenoxy-5-sulphamoyl3Q benzoic acid methyl ester are suspended in 150 ml of methanol and are hydrogenated with Raney nickel (5-10%) in an autoclave 2601 at 4O-5O°C and 100 atmospheres gauge.' The'precipitated amino compound is dissolved by the addition of acetone on a steambath and the Raney nickel is removed by filtration.
On cooling, 3-amino-4-phehoXy-5-sulphamoylbenzoic acid methyl ester crystallises out cleanly,.
Melting point: 179°C. (c) 3-N-SuccinimIdo-4-phenoxy-5-sulphamoylbenzoic acid methyl ester (1) 16.1 g (0.05 mol) of 3-amino-4-phenoxy-5-sulphamoylbenzoic acid methyl ester are dissolved in 150 ml of absolute dioxane and the solution is heated to the boil.
A solution of 11.6 g (0.075 mol) of succinic acid dichloride in 50 ml of absolute acetone and a solution of 8 ml of pyridine in 50 ml of absolute acetone are then added dropwise at the same rate but separately, while stirring well, and the mixture is heated under reflux. The reaction is complete after about 2 hours. The mixture is. concentrated and the residual oil is taken up in a little methanol. 3-N-Succinimldo 4-phenoxy-5-sulphamoylbenzoic acid methyl ester crystallises Out after a short time.
Crystallisation is completed by adding a little water.
Reerystallisation is carried out from methanol/acetone.
Melting point: 27O°C. (ii) 3-Amino-4-phenoxy-5-sulphamoylbenzoic acid methyl ester is fused with a 2-3-fold molar quantity of succinic anhydride, for about 2 hours at 16O-18O°C. On cooling and adding methanol, 3-N-succinimido-4-phenoxy-5sulpham oylbenzoic acid methyl ester crystallises out. (d) 3-N-Pyrrolidino-4-phenoxy-5-sulphamoylbenzoic acid methyl ester 12.3 g (0.03 mol) of 3-N-succInimido-4-phenoxy-5-sulphamoylbenzoic acid methyl ester are dissolved or suspended in -.40-. 43601 100 ml of absolute diglyme, 9 g of boron trifluoride etherate are added direct to this and a solution of 2.4 g (0.063 mol) of NaBH^ in 80 ml of diglyme is then added dropwise at room temperature and with good stirring.
As the reaction proceeds exothermically, it is necessary to cool with ice water. The reaction is normally complete after the dropwise addition and a short period of stirring thereafter.
The excess reducing agent is then decomposed by means of a little water (foaming/), the solution is filtered and about 300 ml of water are added while stirring. The 3-Npyrrolidino-4~phenoxy-5-sulphamoylbenzoic acid methyl ester which has crystallised out is recrystallised from methanol.
Colourless crystals, melting point : 191-192°C.
NMR data: (CDCl^, 60 MHz, TMS as internal standard )6=1.73^.41]) ( 6= 3.26 (m; 4H), 6 = 3.91 (s; 3H), 6 = 5.0(s;2H), ¢=6.6-8.0 (m;7H) in npm.
EXAMPLE 2 3-N-Pyrrolidino-4-phenoxy-5-sulphamoylbenzoic acid g of 3-N-pyrrolidino-4-phenoxy-5-sulphamoylbenzoic acid methyl ester are suspended in 350 ml of IN NaOH and the suspension is heated for one hour on a waterbath. 3-N-Pyrrolidino-4-phenoxy-5-sulphamoylbenzoic acid is precipitated from the clear solution by means of 2 N HCl while stirring well. The almost pure crude product can be recrystallised from methanol/water.
Light yellow platelets, melting point ; 225-227°, with decomposition.
NMR data: (Dg-DMSO, 60 MHz, TMS) δ = 1.67 (quasi-s; 4H), 6=3.21 (quasi-s; 4H), 6 =6.6-8.0 (m; 9H) in ppm. .. 436 01 EXAMPLE 3 ; 3-N-PiperidinO-4-phen0xy-5-sulphamoylbenzoic acid methyl ester (a) 3-N-Glutarimido-4-phenoxy-5-sulphamoylbenzoic acid methyl ester 16.1 g of 3-amino-4-phenoxy-5-sulphamoylbenzoic acid methyl, ester are dissolved in 150 ml Of absolute dioxane and the solution is heated to the boil. A solution of 16.8 g of glutaric acid dichloride in 50 ml of absolute 10 acetone and a solution of 8 ml of pyridine in 50ml of absolute acetone are then added dropwise at the same rate,’while stirring well, and the mixture is heated under reflux. The reaction is complete after about 3 hours. The mixture is concentrated and the residue is taken up in a little ..methanol. 3 -N-Glutarimido-4-phenoxy-5-sulphamoylbenzoic acid methyl ester crystallises out after a short time. It can be reerystallised from glycol monomethyl ether. Colourless crystals, melting point 312-314°C, with decomposition. (b) 3-N-Piperidirto-4-phenoxy-5-sulphamoylbenzoic acid 2q methyl ester .15 g of 3-N-glutariffiido-4-phenoxy-S-sUlphamoylbenzOic acid methyl ester are suspended in 200 ml of diglyme (diethylene glycol dimethyl ether) ahd 10 ml of boron trifluoride etherate are added. A solution of 3 g of NaBH^ in 150 ml of diglyme. is then added.slowly at room temperature with good stirring.
The excess reducing agent is then decomposed with a little water, the solution is filtered and 500 ml of water are added, while stirring. The 3-N-piperidino-4-phenoxy-5-sulphamoylbenzoic acid methyl ester which has crystallised out can be reerystallised from alcohol.
White crystals, melting point 198-199°C.
NMR data: (Dg-DMSO, 60 MHz, TMS) δ= 1,1 (quasi-s; 6H), δ= 2.86 (quasi-s; 4H), δ = 3.92 (s; 3H) ,δ =6.7-8.1 (m;9H) in ppm.
EXAMPLE 4 3-N-Piperidino-4-phenoxy-5-sulphamoylbenzoic acid g of 3-N-piperidino-4-phenoxy-5~sulphamoylbenzoic acid methyl ester are suspended in 50 ml of 1 N NaOH and the suspension is heated on a steam bath until a clear solution is formed. The resulting 3-N-piperidino-4-phenoxy-5sulphamoylbenzoic acid is precipitated with 2 N HCl and is recrystallised from methanol/water.
White crystals, melting point 258-260°.
NMR data: (Dg-DMSO, 60 MHz, TMS) 6= 1.08 (quasi-s;6H), 5=2.9 (quasi-s; 4H), &- 6.65 - 8.2 (m; 9H) in ppm.
EXAMPLE 5 3-N-isoindolinyl-4-phenoxy-5-sulphamoylbenzoic acid methyl ester (a) 3-N-Phthalimido-4-phenox^-5-gu£phamoylbenzoic acid g of 3-amino-4-phenoxy-5-sulphamoylbenZoic acid i methyl ester are dissolved in 200 ml of absolute dioxane and the solution is heated to the boil. A solution of 14 ml of phthalic acid dichloride in 50 ml of acetone and a solution of 9 ml of pyridine in 50 ml of acetone are then added dropwise at the same rate, while stirring Well. The reaction is complete after 3 hours. The solution is concentrated and the residue is taken up in a little acetone and added dropwise, while stirring well, to a mixture of ice water and 2 N HCl. A light brown precipitate of the 3-N-phthalimido-4-phenoxy-5-sulphamoylbenZoic acid methyl ester is formed. Recrystallisation from methanol/acetone/ H^O gives colourless crystals, melting point 237-238°C. ,: 4S601 (b) 3-N-Isoindolinyl-4-phenoxy-5-sulphamoylbenzoic acid methyl ester g of 3-N-phthalimido-4-phenoxy-5-sulphamoylbenzoic acid methyl ester are dissolved or suspended in 150’ml of diglyme and '12 ml of boron trifluoride etherate are added. A solution of 3.6 g of NaBH^ in 100 ml of diglyme is then added dropwise at room temperature and the mixture is stirred for a further % hour at 60°G. On adding 400 ml of water a flocculent mixture of substances separates out. It is boiled up with methanol, during which the 3-N-isoindolinyl4-phenoxy-5-sulphamoylbenzoic acid methyl ester does not dissolve. It is filtered off and recrystallized from n-butanol/DMF.
White needles, melting point; 268-272°, with decomposition.
NMR data: (Dg-DMSO, 60 MHz, TMS) δ = 3.92 (s;3H), 6=4.66 (s; 4H) , 6 = 6.6-8.1 (m; 13H) in ppm.
EXAMPLE 6 3-N-isoindoiinyl-4-phenoxy-5-sulphamoylbenzoic acid 2o ' 2.5 g of 3-N-isoindolinyl-4-phenoxy-5,"shlphamoylbenzoic acid methyl ester are suspended'in 50 ml of 1 N NaOH and the suspension is heated on a steam bath until a clear solution is formed. The 3-N-isoindolinyl-4-phenoxy5-sulphamoylbenzoio acid is precipitated with 2 N HCl and _ is recrystallized from glacial acetic acid.
Light yellow crystals,· melting point 259-261°, With decomposition.
NMR data: (D,-DMS0, 60 MHz, TMS) 6 = 4.68 (s; 4H) , 6=6.6-8.0 (m; 13H) in ppm.
EXAMPLE 7 3-N-(3-Azabicyclo-[3,2.0}-heptano)-4-phenoxy-5-sulpha moylbenzoic aqid methyl ester (a) 3-N-(2,4-Dioxo-3-azabioyclo-(3,2,0)-heptano)-4-phenoxy5-sulphamoylbenzoic acid methyl·ester - ' - 44 43601 8.1 g of 3-amino-4-phenoxy-5~sulphamoylbenzoic acid methyl ester are mixed with 6.3 g of cis-cyclobutane-1,2dicarboxylic acid anhydride and 5 ml of diglyme and the mixture is heated to 180°. In the course thereof the diglyme evaporates off. The melt becomes solid after about 1 hour. Methanol is added while it is still warm. The solid mass disintegrates into a colourless mass of crystals. The crystalline powder is filtered off and recrystallised from glycol monomethyl ether.
Melting point : 284-285°C. (b) 3-N-(3-Azabicyclo-(3.2.0)-heptano)-4-phenoxy-5sulphamoylbenzoic acid methyl ester 7.3 g of 3-N-(2,4-dioxo-3-azabicyclo-[3.2,5]-heptano)-4phenoxy-5-sulphamoylbenzoic acid methyl ester are suspended in 70 ml of diglyne and 6 ml of boron trifluoride etherate are added. A solution of 1.5 g of NaBH^ in 70 ml of diglyne is then added slowly dropwise, with ice cooling. The mixture is stirred for about 15 minutes more and the 3-N-(3-azabicyclo-(3,2,0)-heptano)-4-phenoxy-5-sulphamoylbenzoic acid methyl ester is precipitated by adding water.
Recrystallisation is carried out from methanol or acetonitrile.
White crystals, melting point 176-177°C.
EXAMPLE 8 3-N-(3-Azabicyclo- [3,2,oj-heptano)-4-phenoxy-5-sulphamoylbenzoic acid 6.2 g of 3-N-(3-azabicyclo-p3.2.oj-heptano)-4-phenoxy5-sulphamoylbenzoic acid methyl ester are suspended in 60 ml of 1 N NaOH and the suspension is heated on the waterbath until a clear solution is formed. The acid is then precipitated with 2 N HCl, while stirring well, and is recrystallised from glacial acetic acid.
Pale yellow platelets, melting point 254-255°C, with decomposition.
EXAMPLE 9 3-N-Morpholino-4-phenoxy-5-sulphamoyIbenzoic acid methyl ester (a) 3-N-(3,5-bioxo-morpholiho)-4-phenoxy-5-sulphamoylbenzoic acid methyl ester g of 3-aminO-4-phenOxy-5-sulphamoylbenzoic acid methyl ester are mixed with 15 g of diglycollic acid anhydride and 10 ml of diglyme and the mixture is heated in an open flask to about 180°C. After 1-2 hours, methanol is added cautiously. The imide crystallises out on cooling.
White crystals from diglyme; melting point 295-297°C. (b) 3-N-MorpholinO-4-phenOxy-5-sulpham6ylbenzoic acid methyl ester 9.4 g of 3-N-(3,5-dioxo-morpholino)-4-phenoxy-5-sulphamoyl benzoic acid methyl ester are suspended in 100 ml of diglyme and 6 ml of boron trifluoride etherate are added. A solution 2Q of 1.9 g of NaBH^ in 100 ml of diglyme is then added slowly dropwise, while cooling with ice and stirring well. The . resulting 3-N-morpholino-4-phenoxy-5-sulphamoylbenzoiC acid methyl ester is precipitated by adding water.
Recrystallised from methanol; melting point 221-222°C.
EXAMPLE 10 3-N-Morpholino-4-phenoxy-5-sulphamoylbenzoic . acid The corresponding methyl ester (Example 9) is heated with IN NaOII on a water bath until a clear solution is formed.
The 3-N-morpholino-4"phenoxy-5-sulphamoylbenz0ic acid is precipitated by adding 2 N HCl and is then recrystallised from methanol; brownish white crystals, melting point 194-197°, with decomposition.
EXAMPLE 11 3-N-(4-Methylpiperidino)-4-phenoxy-5-sulphamoylbenzoic acid methyl ester (a) 3-N-(4-Methylglutarimido)-4-phenoxy-5-sulphamoylbenzoic acid methyl ester j g of 3-amino-4-phenoxy-5-sulphamoylbenzoic acid methyl ester and 15 g of 4-methylglutaric anhydride are mixed, with the addition of a little diglyme, to form a slurry which is heated to 160-180°C for 2-3 hours. The 3-N-(4-methylglutarimido)-4-phenoxy-5-sulphamoylben2oic acid methyl ester is precipitated by adding methanol; white crystals from glycol monomethyl ether; melting point 315°C. (b) 3-N-(4-Methylpiperidino)-4-phenoxy-5-sulphamoylbenzoic acid methyl ester .3 g of 3-N-(4-methylglutarimido)-4-phenoxy-5-sulphamoylbenzoic acid methyl ester are suspended in 100 ml of diglyme and 6.5 ml of BF3 etherate are added. A solution of 1.9 g of NaBH4 in 100 ml of diglyme is added dropwise at room temperature. After the dropwise addition, the mixture is stirred for a further 15 minutes and the 3-N-(4-methylpiper*· idino)-4-phenoxy-5-sulphamoylbenzoic acid methyl ester is then precipitated with water; colourless crystals from methanol, melting point 143-144°C.
EXAMPLE 12 3-N-(4-Methylpiperidino)-4-phenoxy-5-sulphamoylbenzoic acid The corresponding methyl ester (Example 11) is heated with 1 N NaOH on a waterbath until a clear solution is formed. The 3-N-(4-methylpiperidino)-4-phenoxy-5-sulphamoylbenzoic acid is precipitated by adding 2 N HCl; white crystals 426 01 from methanol/water, melting point 243-244 EXAMPLE 13 3-N-(3-Methylpyrrolidino)-4-phenoxy-5—sulphamoylbenzoic a'cid methyl ester (a) 3-N-(3-Methylsuccinimldo)-4-phenoxy-5-sulphamoylbenzoic acid methyl ester g of 3—amino-4-phenoxy-5-sulphamoylbenzoic acid methyl ester and 15 g of 3-methylsuccinic anhydride are ’ fused together with a little diglyme in ah Open flask and the mixture is kept at approx. 18O°C for about 2.5 hours. The 3-N-(3-methylsuccinimido)-4-phenoxy-5-SUlphamoylbehzoic acid methyl ester crystallises out on adding methanol.
Recrystallised from glycol monomethyl ether; white crystals, melting point 272°C. (b) 3-N-(3-Methylpyrrolidino)-4-phenoxy-5-sulphamoylbenzoic acid methyl ester g of 3-N-(3-methylsuccinimido)-4-phenoxy-5-sulphamoylbenzoic acid methyl ester are suspended in 150 ml of diglyme, 11 ml of BFj etherate are added and a solution of 3 g of NaBffy in;150 ml of diglyme is then added dropwise while cooling with ice. After the dropwise addition, the resulting3-N-(3methylpyrrolidino)-4-phenoxy-5-sulphamoylbenZ0ic acid methyl ester is precipitated with.water; white crystals from methanol, melting point 145°C.
EXAMPLE 14 25 3-N-(3-Methylpyrrolidino)-4-phenoxy-5-sulphamoylbenzoic acid g of 3-N-(3-methylpyrrolidino)-4-phenoxy-5-sulphamoylbenzoic acid methyl ester are heated in 1 N NaOH on a water bath until a clear solution is formed. The 3-N-(3methylpyrrolidino)-4-phenoxy-5-sulphamoylbenzoic acid is then precipitated at room temperature with 2 N HCl and is recrystallised from CH^OH/^O ; white-yellow crystals, - 48 43601 melting point 206-208°C.
EXAMPLE 15 3-N-Pyrrolidino-4-phenoxy-5~sulphamoylbenzoic acid methyl ester 4.1 g of 3-N-succinimido-4-phenoxy-5-sulphamoylbenzoic acid methyl ester are dissolved in 40 ml Of diglyme and 2.5 ml of titanium tetrachloride are added. A solution of 1.1 g of NaBH4 in 30 ml of diglyme is then added dropwise slowly at room temperature and the mixture is stirred for about 1 hour more.
The resulting 3-N"pyrrolidino-4-phenoxy-5-sulphamoylbenzoic acid methyl ester is precipitated with Water and recrystallised from methanol. Melting point 191°C.
EXAMPLE 16 3-N-Pyrrolidino-4-phenoxy-5-sulphamoylbenzoic acid (a) 3-N-( The 3-N-(m-chloro-butyrylamino)-4-phenoxyr5-sulphamoylbenzoic acid methyl ester is precipitated and is recrystallised from methanol. Melting point 151-153°C. 2601 (b) 3-N-(a]-chlorobutylamino)-4-phenoxy-5-sulphamoyl- . . benzoic acid methyl ester g of 3-N- (u)-chlorobutyrylamino)-4-phenoxy-5-sulphamoylbenzoic acid methyl ester are suspended in 150 ml of diglyme. ml of boron trifluoride etherate are added. A solution of 2.2 g of NaBHj in 150 ml of diglyme is slowly added dropwise at room temperature. Stirring is continued for some minutes and the product is then carefully precipitated with water. Recrystallisation from CH30H, m.p. 125°C. (c) 3-N-pyrrolidino-4-phenoxy-5-sulphamoylbenzoic acid Method C 3-N-(ω-chlarobutylamino)-4-phenoxy-5-sulphamoyl-benzoic acid methyl ester is suspended in IN NaOH and Heated oh a Steam bath until a clear, solution is obtained.. 3-N-pyrrOlidino-4-phenoxy-5-sulphamoyl-benzoic acid (as in Example 2) is precipitated from the cold solution by means of IN HCl.
EXAMPLE 17 4-Chlor.o-3-pyrrolidino-5-sulphamoylbenzoic acid (a) 4-Chloro-3-succinimido-5-sulphamoylbenzoic acid. - methyl ester .4. g of 4-chloro-3-amino-5-Sulphamoylbenzoic acid methyl ester, m.p. 19.5-196°C, are thoroughly mixed with 25 g of succinic acid anhydride and melted for 6 hours at 180°C. The melt is allowed to cool slowly and CH3OH is added carefully. The product crystallizes. A small amount of water added completes the crystallisation.
Recrystallisation from glycol monomethyl ether: m.p. 267-269°C. (bj 4-Chloro-3-pyrrolidino-5-sulphamoylbenzoic acid g of the imide produced in step (a) are suspended in 200 ml of diglyme and 17 ml of BF3 etherate are added. A - 50 42601 solution of 4 g of NaBH^ in 200 ml of diglyme is added dropwise to this suspension while cooling with ice. After the addition, stirring is continued for half an hour and the mixture is then carefully hydrolysed with a small amount of water. The solution is filtered, and 4-chloro-3pyrrolidino-5-sulphamoylbenzoic acid methyl ester is precipitated with water. Recrystallisation from methanol: m.p, 189-191°C. The ester is hydrolysed in IN NaOH on a steam bath until a clear solution has formed. Upon acidification at pH 4, the free acid precipitates.
Light yellow crystals are obtained from CH^OH/H^O.
M.P. 259-261°C.
EXAMPLE 18 3-N-Pyrrolidino-4-phenylthio-5-sulphamoylbenzoic acid (a) 3-N-succinimido-4-phenylthio-5-sulphamoylbenzoic acid methyl ester .8 g of 3-amino-4-phenylthio-5-sulphamoylbenzolc acid methyl ester are mixed with 5.9 g of succinic anhydride and melted at 17O°C. After 5 hours, CHgOH is carefully added while cooling. The substance crystallizes and is recrystallised from glycol monomethyl ether. M.p.25O-251°C. (b) 3-N-Pyrrolidino-4-phenylthio-5-sulphamoylbenzoic acid 14.7 g of the imide produced in step (a) are suspended in 100 ml of diglyme and 10 ml of BF^ etherate are added. 2.8 g of NaBH^ dissolved in 100 ml of diglyme are then slowly added dropwise while cooling with ice. Stirring is continued for half an hour at room temperature and excess reducing agent is destroyed by adding a small amount of water. 3-N-pyrrolidino-4-phenylthio-5-sulphamoylbenzoic acid methyl ester is then precipitated with water and recrystallised from methanol. Yellow crystals having a melting point of 139-14O°C are obtained. The ester is heated 42601 ; ' with IN NaOH on a steam bath until a clear solution is obtained, and the acid formed is then precipitated with IN hydrochloric acid at pH 3-4. Upon recrystallisation from methanol/water, yellow crystals are obtained, m.p, 238-239°C.
* EXAMPLE 19 3-(1-Pyrrolidinyl)-4-phenoxy-5-sulphamoylbenzoic acid a) 3-N-succinimido-4-phenoxy-5-nitro-benzoic acid 10 methyl ester 105 g of 3-amino-4-phenoxy-5-nitrobenzoic acid methyl ester are mixed with 210 g of succinic anhydride and heated for 2 hours to 180°C while stirring. The reaction • - . - -- ri mixture is introduced, with stirring,, into 31 of water 15 and extracted after some time with methylene chloride.
The organic phase is isolated, dried and concentrated.
The residue yields, after recrystallization from methanol, the desired compound melting at 152-154°C in a very good yield. b) 3-(1-Pyrrolidinyl)-4-phehoxy-5-nitrobenzolc acid methyl ester A solution of 44.4 g of the ester obtained according ‘ to aj in -300 ml of diglyme under nitrogen is reacted, while stirring at 0°C, with 34 g of boron trifluoro-dietherate 25 and subsequently with a solution of 9..2 g of NaBH^ in 200 ml of diglyme, while keeping the temperature below +15°C.
After a further hour, water is added dropwise. After completion cf the exothermic reaction, 500 ml of water are added. The desired compound thereupon separates in the form of orange coloured needles melting at 118°-12O°C with a very good yield. - 52 42601 c) 3~(1-Pyrrolidinyl)-4-phenoxy-5-amino-benzoic acid methyl ester Λ solution of 30 g of the nitrobenzoic acid methyl ester obtained according to b) in 500 ml of dioxane is hydrogenated catalytically in the presence of Raney nickel. After completion of the absorption of hydrogen, the mixture is filtered and the filtrate is concentrated. The residue yields, on reerystallization from methanol, the desired compound in the form of colourless crystals melting at 153°156°C in a very good yield. d) 3-(1-Pyrrolidinyl)-4-phenoxy-5-chlorosulphonylbenzoic acid methyl ester A solution of 24.3 g of the amino ester obtained according to c) in 150 ml of concentrated hydrochloric acid is cooled to -5°C and diazotized with a solution of 5.46 g of NaN02 in 40 ml of water, while keeping the temperature below +5°C. After 15 minutes, the light brown solution of the diazonium salt is introduced into a mixture TT of 7.8 g of Cu -chloride dihydrate, 24 ml of concentrated hydrochloric acid and 200 ml of a saturated solution of S02 in glacial acetic acid at 0°C. After completion of the evolution of gas, the mixture is stirred for a short time, then combined with water, and the sulphochloride that has separated is extracted with methylene chloride. The organic phase is washed twice with water, dried and concentrated. The remaining oil yields, upon addition of diisopropyl ether, the desired compound melting at 108°112°C with a very good yield. e) 3-(1-Pyrrolidinyl)-4-phenoxy-5-sulphamoylbenzoic acid methyl ester .0 g of the 5-chlorosulphonyl-benzoic acid methyl ester are introduced portionwise, while stirring, at room temperatures into a mixture of 150 ml of methylene chloride and 75 ml of 25% aqueous ammonia, the mixture is 3601 stirred for 1 hour, the organic phase is separated and washed with water, dried over sodium sulfate and concentrated. The remaining oil is recrystallised from methanol and gives . the 5-sulphamoylbenzoic acid ester melting at 186-188°C with a very good yield.
Saponification of the ester to form the 3-(1-pyrrolidinyl)4-phenoxy-5-sulphamoylbenzoic acid is effected in the manner described in Example 5. Melting point 227-228°C. : EXAMPLE 20 3-(l-Pyrrolidinyl)-4-phenoxy-5-sulphamoylbenzoic acid a) 3-(1-Pyrrolidinyl)-4-phenoxy-5-nitrobenzoic acid g of 3-(l-pyrrolidinyl)-4-phenoxy-5-nitrobenz0ic acid methyl ester (preparation cf. Example 19, step b) are saponified with heating With dilute sodium hydroxide solution.
The orange red solution-is extracted twice with the aqueous phase is then acidified with concentrated hydrochloric acid. The desired acid is isolated in the form of light yellow crystals melting at 228°-23O°C. b) 3-(l-Pyrrolidinyl)-4-phehoxy-5-aminobenzoic acid 32.8 g of the nitrobenzoic acid prepared according to a) are dissolved in a solution of 8 g Of NaOH in 200 ml of whter, cooled to 0°C and combined with a solution of 90 g of sodium dithionite in 380 ml of water, while keeping the temperature below 10°C. The solution which at first is red-orange coloured changes to light yellow. The. solution is stirred for 1 hour without cooling, then acidified to pH 1 by means of concentrated hydrochloric acid and concentrated until crystallisation begins... The hydrochloride of the desired aminobenzoic acid is obtained in the form of colourless crystals melting, at 245°-247°C. . . -4 ..
If the dithionite contains sulfate, there is obtained already before concentration of the aqueous solution the corresponding sulphate in the form of colourless crystals melting at 175°-176°C.
From both, the free amine melting at 100°-103° can be obtained by neutralisation of the aqueous solution to pH 4-4.5. o) 3- (1-Pyrrolidinyl)-4-phenoxy-5-ehloroSulphonyl-benzoic acid A solution of 8.35 g of the aminobenzoic acid hydrochloride prepared according to b) in 25 ml of concentrated hydrochloric acid is diazotized at 0°C with a solution of 1.75 g of sodium nitrite in 15 ml of water, while keeping the temperature below +5°C. After 15 minutes, the solution of the diazonium salt is introduced, while stirring , into a mixture cooled to 0°C of 2 g of Cu-dichloride-dihydrate, ml of concentrated hydrochloric acid and 15 ml of a saturated solution of S02 in glacial acetic acid. After termination of the foam formation, the whole is stirred for 30 minutes, the reaction mixture is subsequently combined with 150 ml of water and extracted several times with ethyl acetate. The organic phase is washed with water, dried, concentrated and, after addition of ether and hexane, yields the crystalline sulphochloride melting at 163°-165°C.
If the aminobenzoic acid sulphate is used, the same sulphochloride is obtained with a somewhat smaller yield. d) 3-(1-Pyrrolidinyl)-4-phenoxy-5-sulphamoylbenzoic acid 7.6 g of the chlorosulphonyl derivative prepared according to c) are introduced in 15 ml of liquid ammonia. The ammonia is removed by evaporation at room temperature and the residue is dissolved in a small amount of water. The solution is filtered and adjusted to pH 1 by means of concen55 36°1 trated hydrochloric acid. The desired sulphamoylbehzbic acid is thereupon obtained in the form of brownish crystals which, upon recrystallisation from methanol/water, yield pale yellow crystals melting at 225°G.
EXAMPLE 21 4-Phenoxy~3- (1-pyrrolidinyl)-5-dimethylsulphamoyl. ' benzoic acid 7.2 g (0.02 mol) of 4-phenoxy-3-(1-pyrrolidinyl)-5sulphamoylbenzoic acid ares dissolved in 3.00 ml of 1 N NaOH 2q . and combined with 10 ml of dime thylsulphate. The mixture is stirred well at room temperature. After about 30 minutes, a white flocculant substance precipitates. It Is filtered off with suction and heated with 2N NaOH on a steam bath.
When a clear solution is formed, the mixture is allowed to cool and the 4-phenoxy-3- (1-pyrrolidinyl)-5-dimethylsulphamoylbenzoic acid is precipitated with the aid of 2 N HCl. The substance can be recrystallized from methanol/water. Yellow : fibers melting at 214°-215°C are obtained.
EXAMPLE 22 . 4-Phenoxy-3-(1-pyrrolidinyl)-5-methylsulphamoyl- . benzoic acid a) 4-Phenoxy-3-N-succinimido-5-methylsulphamoylbenzoic acid methyl ester g of 3-amino-4-phenoxy-5-methyl-sulphamoylbenzoic 25_- acid methyl ester (M.p. 188°C) are fused with 87 g of succinic acid anhydride at 18O°-19O°C. After 5 hours, the molten mass is cautiously combined with methanol and thereafter with tlie same amount of water, whereupon the imide crystallises. The 4-phenoxy-3-N-succinimido-5-methylsulphamoyl30 benzoic acid methyl ester is obtained from methanol and is found to melt at 249°-250°C. b) 4-Phenoxy-3-(1-pyrrolidinyl)-5-methylsulphamoylbenzoic acid methyl ester g of 4-phenoxy-3-N-succinimido-5-methylsulphamoylbenzoic acid methyl ester are suspended in 300 ml of absolute diglyme and combined with 40 ml of boron trifluoride etherate. The mixture is cooled to "10°C and a solution of 12.2 g of NaBH^ in 300 ml of diglyme is added dropwise, while stirring well. The temperature should not rise above 10°C during that time. After the dropwise addition, the mixture is stirred for 10 minutes and then is cautiously combined with water (foaming). Upon further addition of water, the reaction product precipitates. The 4-phenoxy-3-(1pyrrolidinyl)-5-methylsulphamoylbenzoic acid methyl ester melting at 138°-139°C is obtained by recrystallisation from methanol. c) 4-Phenoxy-3-(1-pyrrolidinyl)-5-methylsulphamoylbenzoic acid g of the methyl ester obtained according to b) are suspended in 50 ml of 1 N NaOH and heated, while stirring, on the steam bath. When a clear solution has formed,the mixture is allowed to cool and the free acid is precipitated with the aid of 1 Ν-HCl . The 4-phenoxy-3-(1-pyrrolidinyl)-5methylsulphamoylbenzoic acid melting at 245°-248°C with decomposition is obtained by recrystallisation from, methanol/ water.
EXAMPLE 23 4- (41-Methylphenoxy )-3- (1-pyrrolidinyl)-5-sulphamoylbenzoic acid a) 3-N.i.tro-4-(4 ’-methylphenoxy)-5-sulphamoylbenzoic acid. 124 g (0.9 mol) of potassium carbonate are dissolved in 800 ml of water. To this solution, there are added portionwise 1.6 mols of p-cresol and subsequently 112 g (0.4 mol) of 2-chloro-3-nitro-5-carboxy-benzenesulphonamide and the solution is heated to 85°C. The solution is stirred for - 57 4 2601 hours at this temperature, cooled to 25°-3O°C and acidified with Concentrated hydrochloric acid to pH 1.
The oil which thereupon separates is isolated from the . aqueous phase and subjected to steam distillation. Altern5 atively,’it is possible to adjust the pH from 8 to 9, to extract the excess phenol with ethyl acetate and then to acidify the aqueous phase. After having separated the excess p-cresol in this manner, the product crystallises upon cooling. By recrystallisation from acetone/HjO, the 3-nitro-4-(4'-methyIphenoxy)-5-sulphamoylbenzoic acid melting at 236°C is obtained. b) 3-Nitro-4-(4'-methyiphenoxy)-5-sulphamoylbenzoic acid methyl ester The crude, product obtained according to a) is dissolved j.5 in methanol and heated to the boiling temperature. Then, 5-10% of concentrated sulfuric acid (in relation to the benzoic acid used) are added and the whole is boiled for 8 hours under reflux. The solution is concentrated to one third and cooled to.5°-10°C. The methyl ester crystallises.out: crystals 2q melting at 161°-162°C. c) 3-Amino-4-(4'l-methylphenoxy)-5’-sulphamoylbenzoic acid methyl ester . . gof 3-nitro-4-(4’-methyiphenoxy)-5-sulphamoylbenzoic acid methyl ester are suspended in 150 ml of ethyl acetate and hydrogenated for 5 hours with Raney nickel at 50°G and a hydrogen pressure of 100 atmospheres gauge. After cooling, the Raney nickel is separated and the solution is concentrated to dryness. The 3-amino-4-(4'-methyiphenoxy)-4-sulphamoylbenzoic acid methyl ester is recrystallised from methanol/ jq H20. Crystals melting at 183°-185°C. 43601 d) 3-N-Succinimido-4-(4'-methylphenoxy)-5-sulphamoylbenzoic acid methyl ester g (^0.08 mol) of 3-amino-4-(4’-methylphenoxy)-5sulphamoylbenzoic acid methyl ester are fused with 24 g (0.24 mol) of succinic anhydride for 4 hours at 17O°-19O°C.
During cooling of the molten mass, methanol and a small amount of water are added with care. The imide precipitates and is recrystallised from CH3OH/H2O. Crystals melting at 24O°-241°C. e) 4-(4'-Methylphenoxy)-3-(1-pyrrolidinyl)-5-sulphamoylbenzoic acid methyl ester .6 g of 3-N-succinimido-4~(4’-methylphenoxy)-5-sulphamoylbenzoic acid methyl ester are suspended in 150 ml of absolute diglym and 16 ml of BF3-etherate are added. A solution of 4.6 g of NaBH^ in 200 ml of absolute diglyme is then added dropwise and slowly, while cooling with ice and stirring well. During that time, the temperature should not rise above 20°C. Stirring is continued for 15 minutes and eventually the product is precipitated with water, Reerystallisation from CH30H; crystals melting at 156°157°C. f) The methyl ester obtained according to e) is suspended in 1 N NaOH and heated on a steam bath until a clear solution has formed. The mixture is filtered and acidified to pH 3.
The 4-(4'-methylphenoxy)-3-(1-pyrrolidinyl)-5-sulphamoylbenzoic acid that has precipitated is recrystallised from methanol; light yellow crystals melting at 23O°-233°C with decomposition.
EXAMPLE 24 4-(4’-Methoxyphenoxy)-3-(1-pyrrolidinyl)-5-sulphamoylbenzoic acid a) 3-Nitro-4-(4'-methoxyphenoxy)-5-sulphamoylbenzoic acid The reaction is carried out with £-methoxyphenol in a manner analogous to that described in Example 23a). The product is recrystallised from acetone/water and has a melting point of 233°-234°C. b) 3-Nitro-4-(4'-methoxyphenoxy)-5-sulphamoylbenzoic acid methyl ester This compound is produced in a manner analogous 5 to that described in Example 23b). Becrystallisation from methanol; M.p. 15O°-152°C. ~ cj 3-Amino-4-(4‘-methoxyphenoxy)-5-sulphamoylbenzoic acid methyl ester This compound is produced in a manner analogous to that described in Example 23c). Recrystallisation from methanol; M.p. 176°-177°C. d) 3-N-succinimido-4-(4’-methoxyphenoxy)-5-sulphamoylbenzoic acid methyl ester This compound is produced in a manner analogous to j.,. that, described in Example 23d). M.p. 226°-227°C. e) 4-(41-Methoxyphenoxy)-3-(1-pyrrolidinyl)-5-sulphamoylbenzoic acid methyl ester.
This compound is produced in a manner analogous to that described in Example 23o). M.p. 19O°-191°C. f) 4-(4 '-rMethoxyphenoxy-3-(1-pyrrolidinyl)-5-sulphamoylbehzoic acid is prepared in a manner analogous to that described in Example 23f) and recrystallised from ‘methanol/water. Light yellow crystals melting at 228°-229°C.
EXAMPLE 25 4-(3',5'-Dimethylphenoxy)-3-(1-pyrrolidinyl)-5~ sulphamoylbenzoic acid a) 3-Nitro-4-(3',5’-dimethylphenoxy)-5-sulphamoylbenzoic acid The. reaction is carried out with 3,5-dimethyIphenol in 30 a manner analogous to that described in Example 23a). The raw product so obtained is directly esterified. 4 2 C 01 b) 3-Nitro-4-(3',5'-dimethylphenoxy)-5-sulphamoylbenzoic acid methyl ester This compound is obtained in a manner analogous to that described under Example 23b), recrystallisation from methanol. M.p. 197°-198°C. c) 3-Amino-4-(3',5'-dimethylphenoxy)-5-sulphamoylbenzoic acid methyl ester This compound is obtained in a manner analogous to that described under Example 23c), recrystallisation from methanol, M.p. 195°-196°C. d) 3-N-Succinimido-4-(3',5'-dimethylphenoxy)-5-sulphamoylbenzoic acid methyl ester This compound is obtained in a manner analogous to that described under Example 23d), recrystallisation from methanol, M.p. sintering from 22O°C onwards. e) 4-(31,5'-Dimethylphenoxy)-3-(1-pyrrolidinyl)-5sulphamoylbenzoic acid methyl ester This compound is obtained in a manner analogous to that described under Example 23e), recrystallisation from methanol. M.p. 2O8°-2O9°C. f) In a manner analogous to that described in Example 23f), 4-(3',5'-dimethylphenoxy)-3-(1-pyrrolidinyl)-5-sulphamoylbenzoic acid is obtained and reerystallised from methanol/ water; M.p. 246°-248°C with decomposition.
EXAMPLE 26 4-(4'-Chlorophenoxy)-3-(1-pyrrolidinyl)-5-sulphamoylbenzoic acid a) 3-Nitro-4- (4’-chlorophenoxy)-5-sulphamoylbenzoic acid. This compound is prepared with £-chlorophenol in a manner analogous to that described in Example 23a), Recrystallisation from acetone/water; M.p. 248°C. 2601 b) 3-Nitro-4- (4' -chlorophenoxy) -5-sulphainoyIbenzo'ic acid methyl ester In a manner analogous to that described in Example 23b) the above compound is obtained; recrystallisation from methanol; M.p. 171°-172°C. c) 3-Amino-4-(4'-chlorophenoxy)-5-sulphamoylbenzoic acid methyl ester In a manner analogous to that described in Example 23c), this compound is obtained; recrystallisation from methanol; M.p. 198°-199°C, d) 3-N-SuccinimidO-4-(4'-chlorophenoxy)-5-sulphamoylbenzoic acid methyl ester in a manner analogous to that described in Example 23d) this compound is Obtained; recrystallisation from methanol; M.p, 266°-267°C. ej 4-{4'-Chlorophenoxy)-3-(1-pyrrolidinyl)-5-sulphamoyibenzoic acid methyl ester.
In a manner analogous to that described in Example 23e) this compound is obtained; recrystallisation from methanol/water; M.p. 200°C. f) 4-(4'-Chlorophenoxy)-3-(1-pyrrolidinyl)-5-Sulphamoy1benzoic acid In a manner analogous to that described in Example 23d) this compound is obtained; recrystallisation from methanol; M.p. 253°-254°C.
EXAMPLE 27 / 4- (3'-Trifluoromethylphenoxy)-3-(1-pyrrolidinyl)-5sulphamoylbenzoic acid a) 3-Nitro-4-(3'-trifluoromethylphenoxy)-5-sulphamOyl- . benzoic acid This compound is obtained in a manner analogous to that described in Example 23a) with 3-trifluoromethylphenol. Recrystallisation from acetohe/water. M.p. 2l0°C. - 62 42601 b) 3-Nitro-(3'-trifluoromethylphenoxy )-5-sulphamoylbenzoic acid methyl ester This compound is obtained in a manner analogous to that described in Example 23b); recrystallisation from methanol; M.p. 141°-143°C. c) 3-Amino-4- (3'-trifluoromethylphenoxy)-5-sulphamoylbenzoic acid methyl ester This compound is obtained in a manner analogous to that described in Example 23c); recrystallisation from methanol; M.p. 186°-187°C. d) 3-N~Suceinimido-4~(3'-trifluoromethylphenoxy)-5-sulphamoylbenzoic acid methyl ester This compound is obtained in a manner analogous to that described in Example 23d,; recrystallisation from methanol; M.p. 227°-228°C. e) 4-(3'-Trifluoromethylphenoxy)-3-(1-pyrrolidinyl)-5sulphamoylbenzoic acid methyl ester This compound is obtained in a manner analogous to that described in Example 23e); recrystallisation from methanol; M.p. 17O°-171°C. f, 4-(3'-Trifluoromethylphenoxy)-3-(1-pyrrolidinyl)-5sulphamoylbenzoic acid This compound is obtained in a manner analogous to that described in Example 23f); recrystallisation from glacial acetic acid; M.p. 23O°-234°C.
EXAMPLE 28 3-(1-Pyrrolidinyl)-4-phenoxy-5-sulphamoylbenzoic acid a) 3,5-Dinitro-4-phenoxy-benzoic acid methyl ester g of 3,5-dinitro-4-phenoxy-benzoic acid in 200 ml of methanol are combined with 3 ml of concentrated sulphuric acid and the mixture is boiled for 3 hours under reflux. After evaporation of the solvent, the residue is dissolved in ethyl acetate, and traces of unreacted acid are destroyed with dilute sodium bicarbonate solution. After drying Of the ethyl acetate solution, the solvent is eliminated by evaporation, the residue is recrystallised from ethyl acetate/methanol. The desired.ester melting at 171°-173°C is Obtained with a very good yield, b) 3,5-Diamino-4-phenoxy-benzoic acid methyl ester g of 3,5-diamino -4-phenoxy-benzoic acid methyl ester are dissolved in 250 ml of ethyl acetate, combined • with 10 g of Raney nickel and hydrogenated. After absorption of the calculated amount of hydrogen, the catalyst is filtered off and the solvent is removed, whereupon the remaining oil crystallises. The raw product may be further reacted directly or may be recrystallized from methanol/ water, whereby the diamino ester is obtained in form of colorless crystals melting at 14O°-142°C in excellent 15 yield. Alternatively, the hydrogenation is carried out in an autoclave at 50°G and 100 atmospheres gauge pressure.
The reaction time is then 3 to 5 hours, depending on. the reactivity of the Raney nickel. c) 3-Succinylamino-4-phenoxy-5-amino-benzoic acid 2o methyl ester g of 3,5-diamino-4-phenoxy-benzoic acid methyl ester in 300 ml of chloroform or methylene chloride are stirred for 8 hours Λ at room temperature, with 12.8 g of succinic acid anhydride, whereupon the desired benzoic acid methyl ester separates in the form of a colourless precipitate.
The crystals that have separated are isolated, washed with chloroform and recrystallised from methanol. The 3-succinylamino4-phenoxy-5-amino-benzoic acid methyl ester melting at 190°192°C is obtained in the form of colourless crystals. 42G01 d) 3-(l-Succinimido)-4-phenoxy-5-amino-benzoic acid methyl ester g of 3-succinylamino-4-phenoxy-5-amino-benzoic acid methyl ester are introduced into a mixture of 260 ml of orthophosphoric acid and 60 g of P2°5f the mixture Is heated for 2 hours to 50°C, then cooled and introduced into 750 ml of water. The 3-(succinimido)-4-phenoxy-5-aminobenzoic acid methyl ester is isolated in the form of colourless crystals melting at 2OO°C-2O1°C with almost quantitative yield. e) 3-(l-Pyrrolidinyl)-4-phenoxy-5-aminobenzoic acid methyl ester A solution of 24 g of 3-(1-succinimido)-4-phenoxy-5aminobenzoic acid methyl ester in 180 ml of diglyme is combined with 20 g of boron trifluoride-etherate and cooled to 10°C. A solution of 5.7 g of NaBH^ in 125 ml of diglytna is added dropwise, while cooling, to the reaction mixture in such a manner that the temperature does not rise above 15°C. After completion of the addition, the reaction mixture is stirred for 1 hour and then decomposed cautiously with 300 ml of water. The solid substance that has precipitated is isolated and crystallized from methanol.
The 3-(1-pyrrolidinyl)-4-phenoxy-5-amino-benzoic acid methyl ester melting at 154°-156°C is isolated with excellent yield. f) 3-(1-Pyrrolidinyl)-4-phenoxy-5-sulphamoylbenzoic acid The reaction order described in Example 19 is repeated. Using the 3- (1-pyrrolidinyl)-4-phenoxy-5-ehlorosulphonylbenzoic acid methyl ester, there is obtained by reaction with concentrated ammonia the desired 3-(1-pyrrolidinyl)-4-phenoxy5-sulphamoylbenzoic acid methyl ester (M.p. 186°-188°C) which can be converted by heating with sodium hydroxide solution and subsequent acidification into the desired 3-(1-pyrrolidinyl)4-phenoxy-5-sulphamoylbenzoic acid melting at 226°-228°C. 43601 • EXAMPLE 29 3- (1-Pyrrolidinyl)-4-phenoxy-5-sulphamoylbenzoic acid Steps, a) to c) of the reaction described in Example 5 28 are repeated, then, 10 g of the '3-succinylamino-4phenoxy-5-aminc>benzoic acid ester are stirred for 2 hours at 200°C. After cooling, the reaction mixture is recrystallised from methanol and 3-succinimido-4-phenoxy-5amino-berizoic acid methyl ester is obtained with good yield. 1Q M.p. 199°-2OO°C.
The product so obtained is converted in the manner described in Example 28 into the desired 3-(1-pyrrolidinyl)4-phenoxy-5-sulphamoylbenZoic acid melting at 227°-228°C.
EXAMPLE 30 3-(1-Pyrrolidinyl)-4-phenoxy-4-sulphamoylbenzoic acid - .
The reaction sequence described In Example 28 is repeated to the end of step e). g of 3-(1-pyrrolidinyl)-4-phenOxy-5-amino-benzoic acid methyl ester in 780 ml of IK sodium hydroxide solution are boiled for 2 hours, whereupon a clear solution forms. The reaction mixture is subsequently cooled, adjusted to pH 4 and the product that has precipitated is dissolved in 60 ml of 2N HCl. After standing for a short time, the hydrochloride of 3-(1-pyrrolidinyl)-4-phenoxy-5-aminobenzoic acid melting at 245°-257°C crystallises in beautiful crystals. Mixed melting point with the product of Example 20 (stepb); 252-254°C.
The hydrochloride of 3-(1-pyrrolidinyl)-4-phenoxy-5aminobenzoic acid is converted in the manner described in Be ample 20 via 3-(1-pyrrolidinyl)-4-phenoxy-5-chlorosulphonylbenzoic acid into the desired3-(1-pyrrolidinyl)-4-phenoxy5-sulphamoylbenzoic acid melting at 225O-226°C. - 66 42001 EXAMPLE 31 4-(41-Methylphenoxy)-3-N-(3-methylpyrrolidinyl)-5sulphamoylbenzoic acid a) 3-N-(3-Methylsuccinimido)-4-(4'-methylphenoxy)-5sulphamoylbenzoic acid methyl ester g of 3-amino-4-(4*-methylphenoxy)-5-sulphamoylbenzoio acid methyl ester (cf. Example 28c) are fused with 18 g of methylsuccinic anhydride for 3 hours at 180°C.
During cooling of the molten mass, the product crystallises on addition of methanol . It is recrystallised from acetone/ water. M.p. 229°-23O°C. b, 4-(4'-Methylphenoxy)-3N-(3-methylpyrrolidinyl)-5sulphamoylbenzoic acid methyl ester g of 3-N-(3-methylsuccinimido)-4-(4'-methylphenoxy)5-sulphamoylbenzoic acid methyl ester are suspended in 200 ml of absolute diglyme and combined with 13 ml of BF3~etherate. A solution of 3.3 g of NaBH^ in 200 ml of diglyme is then added dropwise and slowly, while stirring well, at -5° to 0°C. Stirring is continued for 1 hour and the product that has formed is precipitated with water. Recrystallisation from methanol/water M.p. 177°-178°C. c) 4-(4'-Methylphenoxy)-3-N-(3-methylpyrrolidinyl)-5sulphamoylbenzoic acid g of methyl ester (46 b) are suspended in 150 ml of ΙΝ-NaOH and heated on the steam bath, while stirring well. When a clear solution has formed, stirring is continued for 1 hour and the mixture is acidified with 2N-HC1 to a pH of ~3, while cooling with ice. The product that has precipitated is filtered off with suction, washed thoroughly with water and recrystallised from methanol/water. M.p. 22O°-221°C.
EXAMPLE 32 4-Phenoxy-3-(1-pyrrolidinyl)-5-sulphamoylbenzoic acid 436 0 i ' : . ·. ί a) 4-Chloro-5-N,N-dimethylaminomethyleneaminosulphonyl' benzoic acid mi (1,25 mol) of thionyl chloride are added dropwise, at -10°C, to a solution of 58.9 g (0.25 mol) of 4-chloro-55 sulphamoylbenzbic acid in 183 g (2.5 mols) of dimethylformamide (DMF). The solution is then allowed to reach room temperature, stirred for 2 hours and poured on ice, the precipitate is filtered off and washed with water until neutral. The 4-chloro5-N,N-dimethylaminomethyleneamino-sulphonylbenzoic acid is obtained with very good yield in the form of crystals melting at 266°-267°C. b) 3-Nitro-4-chloro"5-N,N-dimethylaminomethyleneamino- sulphonylbenzoic acid 42 ml of fuming nitric acid are added dropwise,. while cooling with ice, to 60 ml of 20% oleum, then 34.9 g (0.12 mol) of ,4-chloro-5-N,N-dimethylaminomethyleneaminosulphonyibenzoic acid are introduced slowly. After having stirred for 24 hours at 55°-6O°C, the solution is cooled to room temperature, poured onto ice and the precipitate is 20 washed with water until neutral. 3-Nitro-4-chloro-5-N,Ndimethylaminomethyleneaminosulphonylbenozic acid is obtained in the form of crystals melting at 274°-276°C. c) 3-Nitro-4-chloro-5-N,N-dimethylaminomethyleneaminosulphonylbenzoic acid methyl ester 50.4 g (0.15 mol) of 3-nitro-4-chloro-5-N,N-dimethylaminomethyleneaminosulphonylbenzoic acid are boiled for 1 hour under reflux in a solution of 150 ml of thionyl chloride which contains 5 drops of DME. After removal of the excess thionyl chloride under reduced pressure, the solid acid chloride is suspended in 200 ml of methanol. The suspension is boiled for hour under reflux, then cooled, filtered and washed with cold methanol. - 68 42601 3-Nitro-4-Chloro-5-N,N-dimethylaminomethyleneaminosulphonylbenzoic acid methyl ester is obtained in the form of crystals melting at 168°-169°C. d) 3-Nitro-4-phenoxy-5-N,N-dimethylaminomethyleneaminosulphonylbenzoic acid methyl ester A solution of 105 g (0.3 mol) of 3-nitro-4-chloro-5N,N-dimethylaminomethyleneaminosulphonyl-benzoic acid methyl ester and 47.5 g (0.36 mol) of potassium phenolate in 600 ml of DMF is boiled for 2 hours under reflux. After cooling and removal of the potassium chloride by filtration, the solution is poured onto ice/water and stirred for 1 hour. T The precipitate is filtered off, washed with water and dried.
After dissolution of the raw product in 900 ml of acetone, the solution is clarified with charcoal, evaporated to 500 ml and diluted with 1 litre of methanol. After having stirred for 1 hour at 10°C, the precipitate is filtered off and washed with cold methanol. 3-Nitro-4-phenoxy-5-N,N-dimethylaminomethyleneamino" sulphonyl-benzoic acid methyl ester is obtained in the form of crystals melting at 191°-193°C. e) 3-Amino-4-Phenoxy-5-N,N-dimethylaminomethyleneaminosulphonylbenzoic acid methyl ester g (0,15 mol) of 3-nitro-4-phenoxy-5-N,N-dimethylaminomethyleneaminosulphonylbenzoic acid methyl ester are hydrogenated with Raney nickel in methanol at room temperature and normal pressure for 8 hours. After filtration, the catalyst is suspended in warm DMF, filtered and the DMF filtrate is poured into a mixture of ice and water. 3-Amino-4-phenoxy-5-N,N-dimethylaminomethyleneaminosulphonylbenzoic acid methyl ester is obtained in the form of crystals melting at 255°-256°C. 42G01 f) 3-rN-Succinimido-4-phenoxy-5-N,N-diinethylaininomethyleneaminosulphonyl-benzoic acid methyl ester 30 g of 3-amino-4-phenoxy-5-N,N-dimethylaminomethyleneaminosulphonyl-benzoic acid methyl ester are 5 fused at 180°C with 25 g of succinic anhydride. After a reaction time of about 2 hours, the imide that has formed is precipitated with methanol. The imide melting at 283°-284°C is obtained with very good yield by recrystallisation. from n-butanol. 1Q g) 4-Phenoxy-3-(1-pyrrolidinyl)-5-N,N-dimethylaminomethyleneaminosuXphonyl-benzoic acid methyl ester 23 g (0.05 mol) of 3-N-succinimido-4-phenoxy-5-N,Ndifflethylaminomethyleneaminosulphonyl-benzoic acid methyl ester are suspended in 200 ml of diethylehe glycol-dimethyl ether (diglyme) and 13 ml of BF^-etherate (0.1 mol) are added. Then, a solution of 3.8 g (0.1 mol) of NaBH^ in 200 ml of diglyme. is added dropwise and slowly, while cooling and keeping the temperature in the range of from -10° to +5°C. The mixture is allowed to warm to room temperature, 2θ whereupon a clear solution is formed. The reaction is completed after 1.25 hours. The product precipitates by the addition of water. By recrystallisation from methanol, there is obtained the 4-phenoxy-3-(1-pyrrolidinyl)-5-N,Ndimethylaminomethyleneaminosulphonyl-benzoic acid ester melting at 189°-19O°C. h) 4-Phenoxy-3-(1-pyrrolidinyl)-5-sulphamoylbenzo.Lc acid. g ((*£>.03 mol) of 4-phenoxy-3-(I-pyrrolidinylJ-S-NjNdimethylaminomethyleneaminosulphonyl-benzoic acid methyl ester are suspended in 100 ml of 2N-NaOH and saponified at 8O°-9OaC, while stirring well. When a clear solution has formed, stirring is continued for 1 hour at the same temperature. The solution is cooled to 0°c and 110 ml of 2li-hydrochloric acid are slowly added, while well stirring. The - 70 42601 whole is stirred more intensively for 1/2 hour and the product that has precipitated in fine form is filtered off sharply with suction. The substance is recrystallized from methanol/water. Light yellow platelets melting at 226°-228°C.
EXAMPLE 33 The reaction sequence described in Example 32 is repeated to the end of step c) . The resulting 3-nitro-4chloro-5-N,N-dimethylaminomethyleneaminosulphonyl-benzoic acid methyl ester is subsequently heated with potassium phenolate for 2 hours to 19O°-2OO°C. The reaction mixture is cooled, dissolved in acetone and, after having removed inorganic components, worked up in the manner described, in step d) of Example 32. 3-Nitro-4-phenoxy-5,N,N-dimethylaminomethyleneaminosulphonylbenzoic acid methyl ester is obtained which can be converted in the manner described in Example 32 into the desired final product.
EXAMPLE 34 a) The reaction sequence described in Example 32 is repeated with the difference that the catalytical hydrogenation of the 3-nitro-4-phenoxy-5-N,N-dimethylaminomethyleneaminosulphonyl-benzoic acid methyl ester is carried out in an autoclave at 50°C and 50 atmospheres gauge pressure. After cooling, the desired 3-amino-4phenoxy-5-N,N-dimethylaminomethyleneaminosulphonyl-benzoic acid ester is isolated in the manner described in Example 32 e) , b) The reaction sequence described in Example 32 is repeated with the difference that the catalytic hydrogenation of the 3-nltro-4-phenoxy-5-N,N-dimethylaminomethyleneaminosulphonylbenzoic acid methyl ester is carried out in di71 3 6 01 methyIformamide (DMF) with Raney nickel at room temperature and normal-pressure. After removal of the catalyst by filtration, the DMF solution is poured onto ice. 3-Amino-4phenoxy-5-N,N-dimethylaminomethyleneamino-sulphonyl-benzoic acid methyl ester is obtained; M.p. 255°-256oC.
EXAMPLE 35 The reaction sequence described in Example 32 is repeated with the difference that 4-chloro-5-N,N-dimethylaminomethyleneamino-sulphonyl-benzoic acid methyl ester is used as starting compound. a) 4-Chloro-5~N,N-dimethylaminomethyleneaininosulphonylbenzoic acid methyl ester ml (1.25 mol) of thionyl chloride are added dropwise, at -10°C, to a solution of 74.9 g (0.3 mol) of 4-chloro5-sulphamoylbenzoic acid methyl ester in 183 g (2.5 mols) of dimethylformamide and worked up as described in Example 32. 4Chloro-5-N,N-dimethylaminomethyleneaminosulphonyl-benzoic acid methyl ester melting at 174°-176°C is obtained. b) 3-Nitro-4-chloro-S-N,N-dimethylaminomethyleneamino20 sulphonyl-benzoic acid methyl ester 36.5 g (0.12 mol) of 4-chiorO-5-N,N-dimethylaminomethyleneaminosulphonylbenzoic acid methyl ester are reacted under the same conditions as those described in Example 32b). A mixture Of 3-ni'tro-4-chloro-5,N,N-dimethyl25 aminomethyleneaminosulphonyl-benzoic acid and 3-nitro-4-chloro5-N,N-dimethylaminomethyleneaminosulphonyl-benzoic acid methyl ester is obtained. The mixture id separated by treatment with 5% aqueous sodium carbonate, 3-Nitro-4-chlOro-_ -N,N-dimethylaminomethyleneamino-sulphonylbenzolc acid j methyl ester melting at 168°-169°C and after acidification 3-nitro-4-chloro-5-N,N-dimethylaminomethyleneamihoSulphonylbenzoic acid melting at 270°-272°C are obtained; the - 72 42601 latter can also be converted into the ester in the manner described in Example 32c).
The further reaction is then effected according to the reaction sequence described in Example 32.
EXAMPLE 36 The nitration described in Example 32 is carried out with the difference that the ethyl ester is used instead of the methyl ester. a) 4-Chloro-5-N,N-dimethylaminomethyleneaminosulphonylbenzoic acid ethyl ester ml (1.25 mol) of thionyl chloride is added dropwise at -10°C to a solution of 65 g (0.25 mol) of 4-chloro-4sulphamoylbenzoic acid ethyl ester in 183 g (2.5 mols) of DMF and worked up as described in Example 32. 4-Chloro-5N,N-dimethylaminomethyleneaminosulphonyl-benzoic acid ethyl ester is obtained in the form of crystals melting at 119°-121°C. b) 3-Nitro-4-chloro-5-N,Ν-dimethylaminomethyleneaminosulphonyl-benzoic acid ethyl ester 38.3 g (0.12 mol) of 4-chloro-5-N,N-dimethylaminomethyleneaminosulphonylbenzoic acid ethyl ester are reacted under the same conditions as those described in Example 35. Separation of the nitro-ester and of the nitro-acid is effected as described in Example 35. 3-Nitro4-chloro-5,N,N-dimethylaminomethyleneaminosulphonyl-benzoic acid ethyl ester is obtained in the form of crystals melting at 182°-184°C, and, after acidification of the aqueous solution, 3-nitro-4-chloro-5-N,N-dimethylaminomethyleneaminosulphonyl-benzoic acid is obtained in the form of crystals melting at 27O°-272°c, which, according to melting point and mixture is identical with the carboxylic acid described in Example 32b).
. ‘ EXAMPLE 37 ' 4-Phenoxy-3-(l-pyrrolidinyl)—5-sulphamoyl-benzoiC acid methyl ester 36.2 gof 4-phenoxy-3-(1-pyrrolidinyl)-5-sulphamoyibenzoic acid are dissolved in 200 ml of methanol and 7 ml of concentrated H^SO^ an<3 heated for 4 to 6. hours under reflux. Upon cooling, the ester crystallises. Recrystallisation from methanol ; M.p. 191°C.
EXAMPLE 38 4-Phenylmercapto-3-(1-pyrrolidinyl)-5-sulphamoylbenzoic acid The reaction sequence described in Example 32 for the preparation of 3"hitro-4-chloro-5-N,N-dimethylaminomethyleneaminosulphonylbenzolc acid methyl ester is repeated. a) 3-Nitro-4-phenylthio-5-N,N-dimethylaainomethyleheaminosulphonyl-benzoic acid methyl ester A solution of 21 g (0.06 mol) of 3-nitro-4-chloro-5-N,Ndimethylaminomethyleheaminosulphonylbenzoic acid methyl ester, 7.7 g (0.07 mol) of thiophenol and 8.2 g (0.077 mol) of sodium carbonate in 100ml of DME* is boiled for 2 hours under, reflux. After cooling and filtration,the solution is poured’ onto a mixture of ice and water and stirred for 1 hour.
The precipitate is filtered off, washed with water and dried. The raw product is recrystallised from acetone/methanol. 3-Nitro-4-phenylthio-5-N,N-dimethylaminomethyleneaminosulphonylbenzoic acid methyl ester is obtained in the form of crystals melting at 2O7°C. b) 3-Amino-4-phenylthio-5-N,N-dimethylaminomethyleneaminosulphonylbenzoic acid methyl ester g (0,0047 mol) of 3-nitro-4-phenylthio-5-N,N-dimethylaminomethyleneaminosulphonylbenzoic acid methyl ester are hydrogenated for 8 hours with Raney nickel in 30 ml of DME at room temperature and normal pressure. The catalyst is - 74 43601 removed by filtration with suction, washed with warm DMF and the DMF filtrate is poured onto a mixture of ice and water. 3-Amino-4-phenylthio-5-N,N-dimethylaminomethyleneaminosulphonylbenzoic acid methyl ester is obtained from acetone in the form of crystals melting at 214°-215°C. c) 3-N-Succinimido-4-phenylthio-5-N,N-dimethylaminornethyleneaminosulphonylbenzoic acid methyl ester. g (0.089 mol) of 3-amino-4-phenylthio-5-dimethylaminomethyleneaminosulphonyl-benzoic acid methyl ester are finely triturated with 26.6 g (0.2668 mol) of succinic anhydride and fused for 2 hours at 175°C. After cooling to 150°C, the whole is diluted with 100ml of DMF and the solution is poured slowly onto a mixture of ice and water. The precipitate is filtered off with suction, dried and recrystallised from DMF/CH^OH. M.p. 261°-263°C. d) 4-Phenylthio-3-(1-pyrrolidinyl)-5-N,N-dimethylaminomethyleneaminosulphonylbenzoic acid methyl ester A solution of 5.1 g of NaBH^ in 135 ml of absolute diglyne is added dropwise, at a temperature of 0°-10°C, while stirring well, to a solution of 32 g of 3-N-succinimido-4phenylthio-5-N,N-dimethylaminomethyleneaminosulphonyl-benzoic acid methyl ester and 17.5 ml of BF^-etherate in 135 ml of absolute diglyme. After 2 hours, the whole is hydrolysed and the product is precipitated by further addition of water. e) The raw product that has precipitated is heated under reflux with 2 N-NaOH until a clear solution is formed.
The 4-phenylthio-3-(1-pyrrolidinyl)-5-sulphamoylbenzoic acid is precipitated with the aid of 2N-HC1 and recrystallised from CH3OH/H2O. M.p. 237°-238°C (see also Example 33). - 75 436 01 EXAMPLE 39 4-Phenylthio-3-|jL-(3-methylpyrrolidinylf] -5-sulphamoy1benzoic acid a) 3-Amino-4-phenylthio-5-N,N-dimethylaminomethyleneamino5 sulphonyl-benzoic acid methyl ester A solution of 110 g of 3-nitro-4-phenylthic-5-N,N-dimethylaminomethyleneaminosulphonylbenzoic acid methyl ester in 400 ml of DMF is hydrogenated for 8 hours over λ» 10 g of Raney nickel at 40°C and 100 atmospheres gauge pressure. The catalyst is filtered off and the solution is pouredonto ice. The precipitate is filtered off, dried and recrystallised from acetone, M.p. 214°-215°C. b) 3-N-(3-Methylsuccinimido)-4-phenylthic-5-N,N-dimethy1/ amincmethyleneaminosulphonyl-benzoic acid methyl ester. g (0.1 mol) of 3-amino-4-phenylthio-5-N,N-dimethylaminomethyleneaminosulphonyl-benzoic acid methyl ester are fused with 34 g (0.3 mol) of methylsuccinic anhydride for 2.5 hours at 175°C. After cooling to 150°C, the 2o mixture is diluted with 100 ml of DMF and the solution is poured slowly onto a mixture of ice and water. The precipitate is filtered off with suction and recrystallised . from CH3OH. M.p. 206°-207°C. c) 4-Phenylthio-3- βΐ-(3-methylpyrrolidinyl)J -5-N,N-dirnethylaminomethyleneaminosulphonyl-benzoic acid methyl ester.
A solution of 4.65 g of NaBHj in 120 ml of absolute diglyme is added dropwise at 0-10°C, to a solution of 29.4 g of 3-N-(3-methylsuccinimido)-4-phenylthio-5-N,N-dimethylaminomethyleneaminosulphonyl-benzoic acid methyl ester and 15.9 ml 3q of- BF3-ethera,te in ,.20 ml of absolute diglyrre. After having stirred for 2 hours, the reaction product is precipitated cautiously with Water. Recrystallisation from CH^OH. M.p, 147°148°C. 42801 d) 4-Phenylthio-3-fl-(3-methylpyrrolidinyl)] -5-sulphamoylbenzoic acid. g of the ester of step c) are heated for 2 hours under reflux in 40 ml of 2N-Na0H. A clear solution is formed. After cooling and acidification with 2N-HC1 to pH 2-3, the 4-phenylthio-3-[i-(3-methylpyrrolidinyl)]-5sulphamoyl-benzoic acid precipitates. It is reerystallised from CH30H/H20. Yellow crystals melting at 216°-217°C.
EXAMPLE 40 4-Phenoxy-3-(1-pyrrolidinyl)-5-sulphamoylbenzoic acid a) 3-N-Pyrrolo-4~phenoxy~5-sulphamoylbenzoic acid g of 3-amino~4*-phenoxy-5-sulphamoylbenzoic acid methyl ester are heated under reflux with 5 g of 2,5-diinethoxytetrahydrofuran in 100 ml of glacial acetic acid. After 1.5 to 2 hours, the mixture is stirred into ice-water. The raw product which is thereby precipitated is heated on the steam bath with IN NaOH until a clear solution has formed. Upon acidification with 2N-HC1 the 3-N-pyrrolo-4-phenoxy-5-sulphamoyl benzoic acid precipitates. It can be reerystallised from methanol or glacial acetic acid/water. White grey crystals melting at 214°C. b) 8.8 g of 3-N-pyrrolo-4-phenoxy-5-sulphamoylbenzolc acid methyl ester (raw product) are dissolved in glacial acetic acid and hydrogenated under normal pressure with 1 g of Pd-black. After about 30 hours, the reaction is completed.
If the hydrogenation is carried out in an autoclave at 40°50°C and 100 atmospheres gauge pressure, the reaction is completed already after 5 hours.
The solution is filtered, concentrated and the solid residue is hydrolysed with ΙΝ-NaOH on the steam bath. The clear solution is cooled and acidified with 2N HCl. The 4phenoxy-3-(1-pyrrolidinyl)-5-sulphamoylbenzoic acid is re77 436 01 crystallised from CH^OH/H^O. M.p. 226-227 C.
·· EXAMPLE 41 4-Phenoxyr3-(1-pyrrolidinyl)-5-sulphamoylbenzoic acid g a) 10 g of 3-amino-4-phenoxy-5-sulphamoylbenzoic acid methyl ester together with 25 g of 1,4-dibromobutane and 10 g of Nal in a mixture of acetone and DMF are heated for several days under reflux. The course of the reaction is followed by thin-layer chromatography. When the reaction is completed, the mixture is concentrated to dryness, the excess dibromobutane is extracted with ether, the mixture is decanted and the residue is saponified with IN NaOH. The 4-phenoxy-3-(1-pyrrolidinyl)-5-sulphamoylbenzoic acid is precipitated from the clear solution with the aid of 2N-HC1. b) . 10 g of 3-amino-4-phenoxy-5-N,N-dimethylaminomethyieneaminosuiphonylbenzoic acid methyl ester are heated for 5 hdurs under reflux together with 25 g of 1,4-dibromobutane in dimethylformamide. The reaction mixture is then concen2q trated to dryness, the excess of dibromobutane is extracted with ether, decanted and the remaining red Oil is dissolved in a small amount of methanol. The 4-phenoxy-3-(1-pyrrolidinyl) -N,N-dimethylaminomethyIeneaminosulphonyl-benzoic acid methyl ester crystallises upon standing. It is saponified as described above with sodium hydroxide solution and the 4-phenoxy-3-(1-pyrrolidinyl)-5-sulphamoylbenzoic acid is precipitated with HCl.
EXAMPLE 42 4-PhenylsulfOxy-3-(1-pyrrolidihyl)-5-sulphamoylbenzoic acid A solution of 7.8 g of 4-phenylthio-3-(1-pyrrolldinyl)· - 78 5-sulphamoylbenzoic acid in 130 ml of glacial acetic acid and 20 ml of 30% H902 is stirred at room temperature.
The course of the reaction is followed by thin-layer chromatography. After 20 hours, the solution is poured into 800 ml of ice-water. The precipitate is filtered off with suction and dried. Recrystallization from methanol/ water yields 4-phenylsulphoxy-3-(1-pyrrolidinyl)-5sulphamoylbenzoic acid in the form of yellow crystals melting at 142°-144°C, with decomposition.
EXAMPLE 43 4-Phenylsulphoxy-3-fl-(methylpyrrolidinyl)] -5sulphamoylbenzoic acid A solution of 6 g of 4-phenylthio-3- [j-(methyIpyrrolidinyl)] -5-N,N-dimethylaminomethyleneaminosulphonylbenzoic -Lg acid in 70 ml of glacial acetic acid and 15 ml of 30% H202 is stirred at 5°-2O°C. After 20 hours, the solution is poured into ice-water. The residue is washed with water, dried and hydrolysed for 2 hours at 100°C with 30 ml of 2N-NaOH. The hydrolysate is filtered and acidified in 2Q the cold, while stirring, with 2N-HC1 to pH 2-3; whereupon, 4-phenylsulphoxy-3- |j-(methylpyrrolidinyl)] -5-sulphamoylbenzoic acid precipitates. Recrystallisation from methanol/ water yields yellow crystals melting at 143°-145°C with decomposition.
Claims (31)
1. CLAIMS: . ' ' I, A 5-Sulphamoylbenzoic acid derivative of the general formula I 5 ih which i 2 R and R , which may be identical or different, each represents a hydrogen atom or an alkyl group having from 1 to 4 carbon atoms,and, j.f R^ represents a hydrogen 2 atom, R may also represent an alkoxymethyl group having jo from 1 to 4 carbon atoms in the alkoxy radical, a phenoxymethyl group or a phenylthiomethyl group, R represents a hydrogen atom, a straight or branched chain alkyl group having from 1 to 4 carbon, atoms, a cycloalkyl group, having 5 or 6 ring members, one of which may J5 be replaced by an oxygen or sulphur. atom, a phenyl or benzyl group which may be substituted in the phenyl nucleus by one or more substituents selected from nitro groups, alkyl groups having from 1 to 3 carbon atoms, alkoxy groups having from 1 to 5 carbon atoms and halogen atoms, or 2. O represents a benzhydryl group or a alkanoyloxymethyl group having 2 to 4 carbon atoms in the alkanoyl part. X represents a halogen atom, a CF^ or CCl^ group, a straight or branched chain, saturated or unsaturated aliphatic hydrocarbon group having from 1 to 6 carbon atoms, a benzyl group 25 which may be substituted in the phenyl nucleus by one or more substituents selected from halogen atoms, hydroxy and amino 80 42601 groups, and lower alkyl and lower alkoxy groups, or represents one of the groups -0-R 4 , -S-R 4 , SO-R 4 , SO2~R 4 4 5 4 and NR R , in which R represents a phenyl group which may be substituted by one or more substituents selected from halogen atoms, OH, CF^, and amino groups, alkyl and alkoxy groups having from 1 to 4 carbon atoms, and SOjN^ groups, or represents a straight or branched chain alkyl group having from 1 to 4 carbon atoms which may be substituted by a phenyl,pyridyl, furyl or thienyl group, artd R represents a hydrogen atom, a straight or branched chain alkyl group having from 1 to 4 carbon atoms, and the group 4 5 NR R may also represent a saturated, heterocyclic, 5- or 6-membered ring which may be interrupted by an 0-, N- or S-atom, A represents a single bond, or an alkylene chain of 1 to 3 carbon atoms, which may be unsaturated, interrupted by 0-, N- or S-atoms or substituted by one or more substituents selected from halogen atoms, alkyl, alkoxy, aralkyl, and aryl groups, and mono-nuclear hetero-aromatic rings, or A represents an ortho-phenylene radical or the grouping in which Y represents a single bond or an alkylene group 6 7 having from 1 to 4 carbon atoms, and R and R , which may be identical or different, each represents a hydrogen or halogen atom or an alkyl group having from 1 to 4 carbon atoms.
2. A compound as claimed in claim 1, in which X represents a benzyl, phenoxy, phenylthio, phenylsulphoxy, phenylsulphonyl or anilino group the phenyl ring of which may be substituted by one or more substituents selected from halogen atoms, OH and CFj groups, alkyl groups having from 1 to 4 carbon atoms, 4 3601 alkoxy groups having from 1 to 3 carbon atoms, and alkyland dialky1-amino groups.
3. A compound as claimed in claim 1, in which A represents a or -CH=CH- group which may be 5 substituted by one or more substituents selected from halogen atoms, lower alkyl, lower alkoxy, and aralkyl groups or by a phenyl group.
4. A compound as claimed in claim 1, in which X and A have the meanings specified in claims 2 and 3 respectively.
5. 3-N-Pyrroiidino-4-phenoxy-5-sulphamoylbenzoic acid or its methyl ester. '
6. 3-N-A3-Pyrrolino-4-phenoxy-5-su,lphgmoylben2oic acid or its methyl ester.
7. 3-N-Piperidino-4-phenoxy-5-sulphamoylbenzoic acid or its methyl ester. 15 · ·
8. 3-N-PyrrolidinQ-4-benzyl-5-sulphamoylbeh2oic acid or its methyl ester.
9. . 3-N-Pyrrolidino-4-(4 1 -methylphenoxy)-5-sulphamoylbenzoic acid or its methyl ester. 20
10. 3-N-(3-Methyl-pyrrolidino)-4-phenoxy-5-sulphamoylbenzoic acid or its methyl ester.
11. 3-N-(3-Methyl-pyrrolidino)-4-(4’-methylphenoxy)-5sulphamoylbenzoic acid or its methyl ester. 82 42601
12. 3-N-Pyrrolidino-4~(4'-hydroxyphenoxy)-5-sulphamoylbenzoic acid or its methyl ester.
13. 3-N-Pyrrolidino-4-(4'-methylbenzylJ-^-sulphamoylhenzoic acid or its methyl ester.
14. A compound as claimed in claim 1 and which is described in any one of the Examples herein, with the exception of the compounds claimed in claims 5 to 13,
15. A salt of a compound as claimed in any one of claims 1 to 14.
16. A physiologically tolerable salt of a compound as claimed in any one of claims 1 to 14.
17. A process for preparing a compound of the general formula I as claimed in claim 1 which comprises a) reducing a 3-substituted sulphamoylbenzoic acid derivative of the general formula II in which the radicals R 3 to R 3 , A and X have the meanings given in claim 1, and in which any hydroxy or amino groups present may be blocked by customary protective groups, and Z represents two hydrogen atoms or one oxygen atom, by means of a boron hydride, or - bj reacting a 5-halogeno-sulphonylbenz0ic acid derivative of the general formula IXI in which R , A and X have the meanings given in claim 1 and Hal represents a halogen atom, with an amine of the formula .R 1 X HN V R 2 in which R and R have the meanings given in claim 1, or c) converting by hydrolysis or by mild oxidation a sulphamoyl compound of the general formula IV (IV) 1 2 in which the radicals R and R , A and' X have the meanings given in claim 1 and D represents a radical which may be transformed, into carboxylic acid groups, into the corresponding 5-sulphamoylhenzoic acid of the formula I, or d) treating a sulphamoylbenzoic acid derivative of 4 2 5 01 the general formula V 1 3 m which the radicals R to R , A and X have the meanings given in claim 1 and L represents a leaving group, with 5 an acid or base in order to eliminate HL, or e) cyclizing a sulphamoylbenzoic acid derivative of the general formula VI in which the radicals R 3- to R 3 and X have the meanings 1 2 given in claim I, Hal and Hal , which may be identical or different, each represents a halogen atom and n represents the number 0, 1 or 2, by a method known per se to form compounds of the general formula I, or f) reducing the corresponding 3-N-pyrrolo-compound of the general formula VII 43601 g) hydrolyzing a compound of the general formula VIII (Vrii) in which R , A and X are as defined above, E represents the group ,8-/in which R®, R® and R 10 represent identical or different 8 - lower alkyl groups and in.which R -may also represent 8 9
18. A hydrogen atom, and/or two of the substituents R , R and R 1 ® may be linked and, together with the atom(s) to which they are attached, form a ring, if desired, in a compound of the formula X obtained according to any one of the methods a) tog), carrying Lg out any one or more of the following reactions h) to k); h) hydrogenating any double bonds present or introducing double bond(s) by an elimination reaction, - 86 42601 ί) esterifying a free carboxylic acid ester of the formula I or converting a carboxylic acid ester of the formula I by hydrolysis or an elimination reaction into the corresponding free carboxylic acid, and, if 5 desired, forming a different ester, j) setting free any protected hydroxy, and/or amino groups by separation of the protective group, and k) converting a carboxylic acid of the formula I by treatment with a base or an acid into a salt thereof. 10 18. Λ process as claimed in claim 17, wherein the boron hydride is used in the presence of a Lewis acid.
19. A process as claimed in claim 18, wherein the boron hydride is a complex borohydride.
20. A process as claimed in claim 17, wherein the 11. 15 compound of formula VI is cyclised by reaction with a metal in accordance with the conditions of the Wurtz-Fittig synthesis or by reaction with a primary amine, NH^ or t/S.
21. A process as claimed in claim 17, conducted substantially as described in any one of the Examples herein.
22. A compound as claimed in claim 1 whenever produced by a process as claimed in any one of claims 17 to 21.
23. A process for preparing a sulphamoylbenzoic acid of the formula I as claimed in claim 1 which comprises hydrolyzing a compound of the formula IXa 4 3 6 01 (VIII) OOR in which A, Ε., X and R J have the meanings given in claim 17 and, if desiied, esterifying a resulting acid.
24. A process for preparing a sulphamoylbenzoic acid of the formula I as claimed in claim 1, which comprises reacting a compound of the formula (IX) with a compound of the formula IO ·· · ’ L~CH 2 -A — CH 2 —L . · in which formulae L, A, R 1 to R 3 , X and.Έ have the meanings given in claim 17.
25. A pharmaceutical preparation which comprises a compound as claimed in any one of claims 1 to 14, claim 16 or claim 22 in admixture or conjunction with a pharmaceutically suitable carrier.
26. , A pharmaceutical preparation as claimed in claim 25, in a form suitable for enteral administration.
27. A pharmaceutical preparation as claimed in claim 25, in a form suitable for parenteral administration.
28. A pharmaceutical preparation as claimed in claim 26 or claim 27 in unit dosage form. 5
29. A pharmaceutical preparation as claimed in claim 28 which comprises from 0.5 to 100 mg of the compound per unit dose.
30. A pharmaceutical preparation as claimed in any one of claims 25 to 29 which also comprises one or more 10 other pharmaceutically active compounds.
31. A pharmaceutical preparation as claimed in claim 30, wherein the other compounds are salidiuretics and/or potassium containing compounds.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2419970A DE2419970C3 (en) | 1974-04-25 | 1974-04-25 | 3- <1-Pyrrolidinyl) -4-phenoxy-5sulfamoylbenzoic acid and process for its preparation |
| DE2461601A DE2461601C2 (en) | 1974-04-25 | 1974-12-27 | 3-Pyrrolidino-4-phenoxy-5-sulfamoylbenzoic acid ester and process for their preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE42601L IE42601L (en) | 1975-10-25 |
| IE42601B1 true IE42601B1 (en) | 1980-09-10 |
Family
ID=25767039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE921/75A IE42601B1 (en) | 1974-04-25 | 1975-04-24 | Sulphamoylbenzoic acid derivatives and processes for preparing them |
Country Status (22)
| Country | Link |
|---|---|
| AR (7) | AR215839A1 (en) |
| AU (1) | AU507614B2 (en) |
| BR (1) | BR7502487A (en) |
| CS (1) | CS188242B2 (en) |
| DD (2) | DD119589A5 (en) |
| DK (1) | DK158978C (en) |
| EG (1) | EG11682A (en) |
| ES (1) | ES453840A1 (en) |
| FI (1) | FI62075C (en) |
| HK (1) | HK51279A (en) |
| HU (1) | HU174751B (en) |
| IE (1) | IE42601B1 (en) |
| IL (2) | IL47128A (en) |
| IT (1) | IT1041753B (en) |
| KE (1) | KE2971A (en) |
| MT (1) | MTP779B (en) |
| MY (1) | MY8000060A (en) |
| NO (5) | NO146745C (en) |
| NZ (1) | NZ177095A (en) |
| RO (6) | RO66590A (en) |
| SE (2) | SE404796B (en) |
| ZM (1) | ZM4875A1 (en) |
-
1975
- 1975-01-25 RO RO7582089A patent/RO66590A/en unknown
- 1975-04-02 NZ NZ177095A patent/NZ177095A/en unknown
- 1975-04-21 IL IL47128A patent/IL47128A/en unknown
- 1975-04-22 ZM ZM48/75A patent/ZM4875A1/en unknown
- 1975-04-23 FI FI751213A patent/FI62075C/en not_active IP Right Cessation
- 1975-04-23 EG EG242/75A patent/EG11682A/en active
- 1975-04-23 IT IT22687/75A patent/IT1041753B/en active Protection Beyond IP Right Term
- 1975-04-23 DD DD185644A patent/DD119589A5/xx unknown
- 1975-04-23 DD DD193161A patent/DD124230A5/xx unknown
- 1975-04-23 AU AU80474/75A patent/AU507614B2/en not_active Expired
- 1975-04-23 AR AR258480A patent/AR215839A1/en active
- 1975-04-24 BR BR3159/75D patent/BR7502487A/en unknown
- 1975-04-24 DK DK179875A patent/DK158978C/en active
- 1975-04-24 HU HU75HO1794A patent/HU174751B/en not_active IP Right Cessation
- 1975-04-24 NO NO751470A patent/NO146745C/en unknown
- 1975-04-24 CS CS765597A patent/CS188242B2/en unknown
- 1975-04-24 IE IE921/75A patent/IE42601B1/en unknown
- 1975-04-25 RO RO7585290A patent/RO81781A/en unknown
- 1975-04-25 RO RO7585292A patent/RO70426A/en unknown
- 1975-04-25 RO RO7585289A patent/RO70346A/en unknown
- 1975-04-25 RO RO7585291A patent/RO70353A/en unknown
- 1975-04-25 SE SE7504841A patent/SE404796B/en not_active IP Right Cessation
- 1975-04-25 RO RO7585293A patent/RO70678A/en unknown
- 1975-05-02 MT MT779A patent/MTP779B/en unknown
-
1976
- 1976-06-25 AR AR263739A patent/AR218225A1/en active
- 1976-06-25 AR AR263742A patent/AR216633A1/en active
- 1976-06-25 AR AR263743A patent/AR217056A1/en active
- 1976-06-25 AR AR263741A patent/AR219057A1/en active
- 1976-06-25 AR AR263740A patent/AR217055A1/en active
- 1976-12-01 ES ES453840A patent/ES453840A1/en not_active Expired
-
1977
- 1977-10-27 SE SE7712097A patent/SE435379B/en not_active IP Right Cessation
-
1978
- 1978-12-13 NO NO784196A patent/NO149736C/en unknown
- 1978-12-13 NO NO784198A patent/NO151825C/en unknown
- 1978-12-13 NO NO784197A patent/NO150681C/en unknown
-
1979
- 1979-03-20 IL IL56919A patent/IL56919A0/en not_active IP Right Cessation
- 1979-06-20 KE KE2971A patent/KE2971A/en unknown
- 1979-07-02 AR AR277151A patent/AR231135A1/en active
- 1979-07-26 HK HK512/79A patent/HK51279A/en unknown
-
1980
- 1980-12-30 MY MY60/80A patent/MY8000060A/en unknown
-
1983
- 1983-08-30 NO NO833116A patent/NO152749C/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4010273A (en) | 5-sulfamoylbenzoic acid derivatives carrying a heterocyclic substituent | |
| US3501495A (en) | N-phenylsulphonyl-n'-(3-azabicycloalkyl) urea derivatives | |
| US4600788A (en) | 4'-flavonecarboxylic acids and pharmaceutically acceptable derivatives their preparation, and their application | |
| US3825574A (en) | Process for preparing substituted chromone-3-carbonitriles,carboxamides and carboxylic acids | |
| US3824271A (en) | 3-alkyl-3-(benzoyl)propionitriles | |
| US3915988A (en) | Benzopyranopyrazolecarboxylic acids | |
| US3424758A (en) | Carboalkoyphenoxy and carboalkoxy-phenylmercapto-4-nitropyrazoles | |
| US4118397A (en) | Derivatives of 5-aminobenzoic acid having a heterocyclic substituent in the 3-position | |
| US3491097A (en) | 3-(piperazinoalkyl)-pyrazoles | |
| US2838521A (en) | Esters of amino alcohols | |
| US3972994A (en) | Disubstituted azabicycloalkanes | |
| IE42601B1 (en) | Sulphamoylbenzoic acid derivatives and processes for preparing them | |
| US3458515A (en) | Piperazine substituted pyrroles | |
| US4139621A (en) | N-(4-substituted-3,5-dichloro-phenyl)-piperazines | |
| US3426017A (en) | Sulfonylurea compounds | |
| US3882119A (en) | Tetracyclic substituted phthalazine compounds | |
| US3709917A (en) | N-acyl and n-organosulfonyl mono-or di-substituted sulfamoylbenzenesulfonamides | |
| US3862140A (en) | 4-hydroxy-2h- 1-benzothiopyran-3-carboxamide 1,1-dioxides | |
| US4492710A (en) | Substituted pyrrolidinyl-benzoic acid derivatives and a process for their manufacture | |
| NZ200258A (en) | Indole derivatives and pharmaceutical compositions | |
| US3465002A (en) | (succinimidoaryloxy)alkanoic acids,esters and amides thereof | |
| US4048313A (en) | Benzene sulphonamides processes for producing the same and pharmaceutical compositions incorporating them | |
| US4143150A (en) | Derivatives of oxanilic acid | |
| US4755523A (en) | Abietamide derivatives | |
| KR830000584B1 (en) | Method for preparing 5-sulfamoylbenzoic acid derivative having a heterocyclic substituent |